BIO logo

  • June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading
Search Filters
  • Date
  • Focus Area
  • Start time
  • Session Type
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
6:30 AM – 9:00 AM
(PST)
  1. KBI Biopharma 5K at BIO 2024
    Session
9:00 AM – 12:00 PM
(PST)
  1. Partnering with the U.S. Government to Achieve Our National Security Mission
    Breakout Session
    • Infectious Disease and Vaccines
    28ABCDE
9:05 AM – 9:40 AM
(PST)
  1. U.S. Engagement Day Opening Remarks
    DOD/BARDA
    • Infectious Disease and Vaccines
    Paul Friedrichs
    Paul Friedrichs, Maj. Gen. (ret), Deputy Assistant to the President - Director of the Office of Pandemic Preparedness and Response at the White House
    David Smith
    David Smith, Deputy Assistant Secretary of Defense for Health Readiness Policy and Oversight - Department of Defense (DOD)
    Dawn O'Connell
    Dawn O'Connell, Assistant Secretary for Preparedness and Response (ASPR), HHS - U.S. Department of Health and Human Services
9:45 AM – 10:40 AM
(PST)
  1. US and Global Partnerships to Achieve Better Global Preparedness and Response
    DOD/BARDA
    • Infectious Disease and Vaccines
    Jennifer Alton
    Jennifer Alton, President - Pathway Policy Group
    Chris Houchens
    Chris Houchens, Director Division CBRN MCMs - BARDA
    Emma Wheatley
    Emma Wheatley, Director, Access and Private Partnerships - CEPI
    Timothy Belski
    Timothy Belski, Branch Chief, Biopharmaceutical Manufacturing Preparedness (BioMaP) - BARDA
    Laurent Muschel
    Laurent Muschel, Acting Director General - European Commission, Health Emergency Preparedness and Response Authority (HERA)
    Brad Norwood
    Brad Norwood, Division Chief, Advanced and Emerging Threats, Joint Science and Technology Office - Defense Threat Reduction Agency
    Nicole Kilgore
    Nicole Kilgore, JPEO-CBRND - Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense/Joint Pro
10:00 AM – 11:00 AM
(PST)
  1. APAC: A Top Rate Destination for Complex and Challenging Clinical Trials
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    novotech
    Judith Ng-Cashin
    Judith Ng-Cashin, Chief Medical Officer - Novotech
    Srini Ramanathan
    Srini Ramanathan, Chief Development Officer - Roivant
    Zach Gobst
    Zach Gobst, Founder and CEO - Leapcure
    Mark Tang
    Mark Tang, Managing Director - Good Health Capital
    Yao Li Ho
    Yao Li Ho, Managing Director - LYFE Capital
    Han Ying
    Han Ying, Chief Executive Officer - Gyre Therapeutics
10:45 AM – 11:30 AM
(PST)
  1. Aiming at a Moving Target: Enabling Technology to Adapt to Evolving Threats
    DOD/BARDA
    • Infectious Disease and Vaccines
    28ABCDE
    Taylor Sexton
    Taylor Sexton, Principal, Health Policy and Medical Countermeasures - Todd Strategy Group
    Arlene Joyner
    Arlene Joyner, Deputy Assistant Secretary Director, Office of Industrial Base Management and Supply Chain, ASPR - HHS
    David Kaslow
    David Kaslow, Director, Office of Vaccine Research and Review, CBER - FDA
    Wolfgang Philipp
    Wolfgang Philipp, Principal Advisor – Chief Science Officer - HERA
    Timothy Schiavoni
    Timothy Schiavoni, Director, Advanced Development and Manufacturing Capabilities (ADMC) - JPL-CBRND Enabling Biotechnologies
11:00 AM – 11:45 AM
(PST)
  1. Funding from a Japanese Investment Perspective
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Amy Nguyen
    Amy Nguyen, Vice President, Business Development and Relationship Management - Catalyst Clinical Research
    Takaaki Tobaru
    Takaaki Tobaru, Partner - Remiges Ventures
    Scott Kahn
    Scott Kahn, Chairman, ICAN Biomarkers Council; Founder - Alykomed Global Solutions LLC
    Ryusuke Sakamoto
    Ryusuke Sakamoto, General Manager, Business Development - Sanwa Kagaku Kenkyusho Co., Ltd.
11:30 AM – 1:00 PM
(PST)
  1. Premier & General Attendee Lunch
    Session Sails Pavilion
11:35 AM – 11:55 AM
(PST)
  1. Unlocking the Door to Government Partnerships
    DOD/BARDA
    • Infectious Disease and Vaccines
    Jeremiah Kelly
    Jeremiah Kelly, Partner - Venable LLP
    Gary Disbrow
    Gary Disbrow, Deputy Assistant Secretary Director - BARDA
    Matt Clark
    Matt Clark, Chemical, Biological, Radiological and Nuclear (CBRN) Medical Joint Project Manager - JPEO-CBRND
    Jennifer Kruk
    Jennifer Kruk, Program Manager, Joint Science and Technology Office (JSTO)/Research and Development, Chem/Bio Technologies - Defense Threat Reduction Agency
12:00 PM – 1:00 PM
(PST)
  1. How to Build a Successful and Competitive Biopharma Ecosystem in Southeast Asia
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Mai Zymaris
    Mai Zymaris, Counsel - Baker McKenzie
    Phong Tran
    Phong Tran, CEO - BOUND Therapeutics and siRnaMed Therapeutics
    John Mattison
    John Mattison, Operating Partner and Chief Medical Information Officer - Arsenal Capital Partners
    Anh Hoang-Lindsay
    Anh Hoang-Lindsay, CEO - Jana Care
    Alex Wang
    Alex Wang, Head of Business Development, US & China - Zuellig Pharma
12:15 PM – 6:00 PM
(PST)
  1. Company Presentations Monday
    Company Presentation Session Company Presentation Theaters
    johnson and johnson
12:30 PM – 1:30 PM
(PST)
  1. Focal Biosciences
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 3
    Glenn Croston
    Glenn Croston, Chief Operations Officer - Focal Biosciences
  2. Hua Medicine
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    George Lin
    George Lin, EVP & Chief Strategy Officer - Hua Medicine
  3. Pepper Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Samantha Dale Strasser
    Samantha Dale Strasser, CSO and Cofounder - Pepper Bio
  4. ReCode Therapeutics
    Company Presentation
    • Other
    Company Presentation Theater 1
    Ariel Kantor
    Ariel Kantor, Head of Business and Corporate Development - ReCode Therapeutics
  5. Sustainable Talent Development for Biomanufacturing of the Future
    BioProcess Theater BioProcess Theater
    Sue Behrens
    Sue Behrens
    Keau Wong
    Keau Wong
    Gargi Ghosh
    Gargi Ghosh, Associate Professor - Keck Graduate Institute
    John Belchunas
    John Belchunas
    Mike Alston
    Mike Alston, Vice President, Operations - Avid Bioservices
12:45 PM – 1:00 PM
(PST)
  1. Avidicure B.V.
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Robert Friesen
    Robert Friesen, Chief Scientific Officer - Avidicure B.V.
  2. Extend Biosciences
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Tarik Soliman
    Tarik Soliman, CEO and President - Extend Biosciences
  3. GenEdit
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Barbara Leyman
    Barbara Leyman, SVP, Corporate Development - GenEdit
  4. VerImmune Inc
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Joshua wang
    Joshua wang, Founder/CEO - VerImmune Inc
1:00 PM – 1:15 PM
(PST)
  1. APAC Summit Networking Lunch
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
  2. Future Medicine
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Jangyoun Hwang
    Jangyoun Hwang, Director - Future Medicine
  3. Neopharmed Gentili S.p.A.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Eric Falcand
    Eric Falcand, CEO - Neopharmed Gentili S.p.A.
  4. Rady Children's Institute for Genomic Medicine
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 1
    Stephen Kingsmore
    Stephen Kingsmore, President & CEO - Rady Children's Institute for Genomic Medicine
  5. VelaVigo
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Tong Zhang
    Tong Zhang, Co Founder, CBO/CFO - VelaVigo
1:15 PM – 1:30 PM
(PST)
  1. Accession Therapeutics Limited
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Stephanie Bewick
    Stephanie Bewick, Chief Business Officer - Accession Therapuetics
  2. AustarPharma,LLC
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Ron Liu
    Ron Liu, CEO - AustarPharma, LLC
  3. Shanghai Synergy Pharmaceutical Sciences Co., Ltd., A wholly owned subsidiary of Huahai Pharmaceutical Co., Ltd.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Min Li
    Min Li, Board Chair - Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
  4. ZTI BIOSCIENCES
    Company Presentation
    • Other
    Company Presentation Theater 1
    Jaden Hyungseok Chang
    Jaden Hyungseok Chang, CEO - ZTI Biosciences
1:30 PM – 1:45 PM
(PST)
  1. Bilayer Therapeutics, Inc.
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Thomas Collet
    Thomas Collet, President & CEO, Co-Founder - Bilayer Therapeutics, Inc.
  2. Esphera SynBio Inc
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Brian Lichty
    Brian Lichty, CEO - Esphera SynBio Inc
  3. Hexagon Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Maureen Hillenmeyer
    Maureen Hillenmeyer, CEO - Hexagon Bio
  4. Humanetics Corporation
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Ronald Zenk
    Ronald Zenk, Chief Executive Officer - Humanetics Corporation
1:45 PM – 2:45 PM
(PST)
  1. A Discussion on Increasing Healthspan
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Hilary Brueck
    Hilary Brueck, Journalist - Business Insider
    Dan Oliver
    Dan Oliver, CEO & Co-Founder - Rejuvenate Bio
    Katharine Grabek
    Katharine Grabek, Co-Founder and CSO - Fauna Bio
    Jake Becraft
    Jake Becraft, CEO & Founder - Strand Therapeutics
    Alex Aravanis
    Alex Aravanis, CEO - Moonwalk Biosciences
    Jennifer Bergheiser
    Jennifer Bergheiser, Chief Business Officer - eGenesis
  2. A Licensing Deal for All Seasons
    Breakout Session
    • Business Development and Finance
    29AB
    Jonathan Grinstein
    Jonathan Grinstein, Senior Editor - Inside Precision Medicine
    Uneek Mehra
    Uneek Mehra, CHIEF FINANCIAL & BUSINESS OFFICER - 4DMT
    Kunal Patel
    Kunal Patel, VP of Business Development - Synthekine
    Gavin Samuels
    Gavin Samuels, Chief Business Officer - CinRx Pharma
    Lesley Stolz
    Lesley Stolz, Vice President - Johnson & Johnson Innovation
    Richard Wilson
    Richard Wilson, Senior VP, Primary Focus Lead of Genetic Regulation - Astellas Gene Therapies
  3. All Money is NOT Created Equal: The Differences between Angel, Venture and Strategic Capital in the Biotech Funding Ecosystem
    Breakout Session
    • Business Development and Finance
    32AB
    Yaniv Sneor
    Yaniv Sneor, Founder & Managing Director - Mid Atlantic Bio Angels
    Jonathan McClain
    Jonathan McClain, Executive Director, Eli Lilly Catalyze team - Eli Lilly
    Max Farina
    Max Farina, Senior Associate - 5AM Ventures
    Alexey Konov
    Alexey Konov, Managing Partner - Biovision Ventures
  4. Alternative Funding Programs: Protecting Patients in an Ever-Changing Healthcare Landscape
    Breakout Session
    • Patient Advocacy
    26A
    Ashira Vantrees
    Ashira Vantrees, Counsel - Aimed Alliance
    Kollet Koulianos
    Kollet Koulianos, Senior Payer Advisor - Hemophilia Alliance
    Kim Czubaruk
    Kim Czubaruk, Associate Vice President of Policy - Cancer Care
    Richard Meyers
    Richard Meyers, Head, State Policy - Bristol Myers Squibb
    Theresa Alban
    Theresa Alban, Senior Manager, Federal Policy - Cystic Fibrosis Foundation
  5. Aurion Biotech
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Greg Kunst
    Greg Kunst, CEO - Aurion Biotech
  6. Bristol Myers Squibb
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Lauren Cautilli
    Lauren Cautilli, Manager, SBD External Event Operations - Bristol Myers Squibb
  7. Building Capacities in the Industry for Secondary Uses of Health Data: The EHDS Framework
    Breakout Session
    • AI and Digital Health
    24BC
    Montse Daban
    Montse Daban, Director of Strategic Foresight at Biocat; President - CEBR
    Jean Marc Bourez
    Jean Marc Bourez, CEO - EIT Heatlth
    Elina Drakvik
    Elina Drakvik, Senior lead, Health Data 2030 - Sitra
    Aenor Sawyer
    Aenor Sawyer, Director UC Space Health - University of San Francisco
    Brad Ship
    Brad Ship, Partner - Alira Health
    Chris Morton
    Chris Morton, Business Executive and CEO - ELEM Biotech
  8. Empowering Real World Patient-Centric Digital Health in Asia with Digital Apps
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Peter Kurz
    Peter Kurz, Chief Strategy Officer - QIC International
    Yen-Yin Lin
    Yen-Yin Lin, Co-founder & CEO - JelloX Biotech Inc.
    Jarret Chia-Ju Su
    Jarret Chia-Ju Su, Co-Head of Healthcare & Life Science - KPMG in Taiwan
    Edward Deng
    Edward Deng, co-founder and CEO - Health2Sync
    Amy Hsiao
    Amy Hsiao, Head of Product Management - Acer Medical
    Steven Lester
    Steven Lester, Cardiologist and Professor in Medicine - Mayo Clinic
  9. Europe's Policy Environment and the Impact on the Biotech Sector
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
    Justin Pine
    Justin Pine, Senior Director - Biotechnology Innovation Organization (BIO)
    Matias Olsen
    Matias Olsen, Public Affairs & Policy Manager - EUCOPE
    Claire Skentelbery
    Claire Skentelbery, Director General - EuropaBio
    Santoke Naal
    Santoke Naal, Managing Director - IGES UK
    Steffen Thirstrup
    Steffen Thirstrup, Chief Medical Officer - European Medicines Agency (EMA)
    Thomas Bols
    Thomas Bols, Head of Government Affairs and Patient Engagement, EMEA & APAC - PTC Therapeutics
  10. Super Session
    Fireside Chat with Nauman Shah, Global Head of Business Development, Johnson & Johnson Innovative Medicine
    Super Session
    • Business Development and Finance
    28ABCDE
    johnson and johnson
    Michelle Davis
    Michelle Davis, M&A Reporter - Bloomberg News
    Nauman Shah
    Nauman Shah, Global Head of Business Development - Johnson & Johnson Innovative Medicine
  11. Glykos Finland Oy
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Juhani Saarinen
    Juhani Saarinen, CEO - Glykos Finland Oy
  12. Lessons from the Oregon Trail: Pioneering Gene Therapy in the Real World
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Tom Klima
    Tom Klima, Chief Operating and Commercial Officer - bluebird bio
    Joe Garrity
    Joe Garrity, Senior Director, Head of Cell and Gene Therapy Customer Proposals - Lonza
    Tim Olson
    Tim Olson, Medical Director, Blood and Marrow Transplant Program - Children's Hospital of Philadelphia
    Michelle Campbell
    Michelle Campbell, Caregiver - N/A
    Kirk Davis
    Kirk Davis, Cigna Healthcare Gene Therapy Program, Senior Manager - Cigna
  13. Tharimmune, Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Sireesh Appajosyula
    Sireesh Appajosyula, Chief Operating Officer - Tharimmune, Inc.
  14. The Cross-Border Applicability of RWD in Decision-Making
    Breakout Session
    • Regulatory Innovation
    31C
    Rachel Ehlers
    Rachel Ehlers, Partner - Baker McKenzie
    Michele Colucci
    Michele Colucci, Founder & Managing Partner - DigitalDx Ventures
    Michelle Wong
    Michelle Wong, Head of Operations - Octant
    Jonathan Fairtlough
    Jonathan Fairtlough, Principal, Advisory, Cyber Security Services - KPMG US
    Virginia Sanzone
    Virginia Sanzone, General Counsel - ICU Medical
  15. The Time is Now: Global Perspectives on Preparing for Public Health Emergencies
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Emergent logo
    Chris Frech
    Chris Frech, Senior Vice President Global Government Affairs - Emergent BioSolutions
    Brett Sutton
    Brett Sutton, Director, Health & Biosecurity - CSIRO
    Wolfgang Philipp
    Wolfgang Philipp, Principal Advisor – Chief Science Officer - HERA
    Oliver Schacht
    Oliver Schacht, Executive VP Corporate Development - OpGen
    Ambika Bumb
    Ambika Bumb, Deputy Executive Director - Bipartisan Commission on Biodefense
2:00 PM – 2:15 PM
(PST)
  1. Bridge Biotherapeutics
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Pavel Printsev
    Pavel Printsev, Director, Business Development - Bridge Biotherapeutics
  2. Digital Transformation for Start-up and Mid-sized Life Science manufacturing sites
    BioProcess Theater BioProcess Theater
    John Clapham
    John Clapham
  3. Genprex, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Ryan Confer
    Ryan Confer, Chief Financial Officer - Genprex, Inc.
  4. Novo Nordisk
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 2
    Tari Suprapto
    Tari Suprapto, Director, Search & Evaluation (Western US & Canada) - Novo Nordisk
  5. StemSynergy Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Dennis Fei
    Dennis Fei, Director of Drug Discovery and Development - StemSynergy Therapeutics
2:15 PM – 2:30 PM
(PST)
  1. Amgen Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Omari Wise
    Omari Wise, Vice President Business Development - Amgen
  2. Cellphire Therapeutics, Inc
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Mike Gaffney
    Mike Gaffney, CEO - Cellphire Therapeutics, Inc
  3. Lisata Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    David Mazzo
    David Mazzo, President and Chief Executive Officer - Lisata Therapeutics
  4. Ocugen, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Shankar Musunuri
    Shankar Musunuri, Chairman, CEO and Co-Founder - Ocugen, Inc.
2:30 PM – 2:45 PM
(PST)
  1. Maryland Tech Council- BioHub Maryland
    Company Presentation Company Presentation Theater 2
  2. Medosome Biotec, LLC
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Richard Wagner
    Richard Wagner, President - Medosome Biotec, LLC
  3. Osmol Therapeutics, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Bob Linke
    Bob Linke, President & CEO - Osmol Therapeutics, Inc.
  4. Protalix Biotherapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Dror Bashan
    Dror Bashan, President & CEO - Protalix Biotherapeutics
2:45 PM – 3:00 PM
(PST)
  1. Evaxion Biotech
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Christian Kanstrup
    Christian Kanstrup, CEO - Evaxion Biotech
  2. Orizuru Therapeutics, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Shinji Ogawa
    Shinji Ogawa, Vice president and Chief Operating Officer - Orizuru Therapeutics, Inc.
  3. PDX Pharmaceuticals
    Company Presentation
    • Oncology
    Company Presentation Theater 4
    Worapol Ngamcherdtrakul
    Worapol Ngamcherdtrakul, COO - PDX Pharmaceuticals
  4. Vivacelle Bio,Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 3
    Cuthbert Simpkins
    Cuthbert Simpkins, President/Chief Innovation Officer - Vivacelle Bio, Inc
3:00 PM – 3:15 PM
(PST)
  1. A New Era for Access and Affordability: Considerations for Patients and Manufacturers in a Post-IRA World
    Breakout Session
    • Patient Advocacy
    26A
    Mark Gooding
    Mark Gooding, Managing Director - Avalere
    Anna Hyde
    Anna Hyde, Vice President of Advocacy and Access - Arthritis Foundation
    Valerie Reynolds
    Valerie Reynolds, Executive Director - Genentech
    Eric Gascho
    Eric Gascho, Senior Vice President, Policy and Government - National Health Council
  2. A Perspective from the Trenches: Challenges of Budgeting for Gene Therapies, Innovative Payment Systems That Work for Medicaid Departments and Patients, and What the States Need from CMS
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Thomas Barker
    Thomas Barker, Partner - Foley Hoag LLP
    Scott McGoohan
    Scott McGoohan, Executive Director, Policy and Alliance Development - Vertex Pharmaceuticals
    Jay Newman
    Jay Newman, SVP, Commercial Development, Pricing & Reimbursement - Spark Therapeutics, Inc.
    Stuart Portman
    Stuart Portman, Executive Director, Division of Medical Assistance Plans - State of Georgia
    James Uli
    James Uli, Senior Vice President and Chief Financial Officer - Rady Children's Hospital and Health Center
  3. Accuredit Therapeutics US limited
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Yongzhong Wang
    Yongzhong Wang, CEO - Accuredit Therapeutics US Limited
  4. AI and Regulatory Innovation in Healthcare: Shaping the Future
    Breakout Session
    • Regulatory Innovation
    31C
    Paul Howard
    Paul Howard, Senior Director of Public Policy - Amicus Therapeutics
    Meredith Brown-Tuttle
    Meredith Brown-Tuttle, Chief Regulatory Strategist - Regulatorium
    Brandon Rice
    Brandon Rice, Chief Product Officer - Weave Bio
    Mida Pezeshkian
    Mida Pezeshkian, Founder, Principle - STEMA_cg
    Christopher Hart
    Christopher Hart, Partner - Foley Hoag
  5. An Insider Look at Top Deals from 2023
    Breakout Session
    • Business Development and Finance
    29AB
    Carin Canale-Theakston
    Carin Canale-Theakston, Executive Biotech Advisor - Inizio
    Mark McKenna
    Mark McKenna, CEO - Mirador Therapeutics
    Enoch Kariuki
    Enoch Kariuki, President - Endeavor Biomedicines
    Ken Song
    Ken Song, former CEO - RayzeBio
    Remy Durand
    Remy Durand - Vertex
  6. Asahi Kasei Pharma corporation
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Takeshi Ohno
    Takeshi Ohno, Executive Officer - Asahi Kasei Pharma Corporation
  7. Biotech Beyond Borders: Emerging Stronger from a Complex Macroenvironment
    Breakout Session
    • Business Development and Finance
    32AB
    Arda Ural
    Arda Ural, Americas Life Sciences Sector Leader - EY (Ernst & Young)
    Chris Garabedian
    Chris Garabedian, VC Portfolio Manager - Perceptive Advisors
    Barbara Ryan
    Barbara Ryan, Board Member, Senior Advisor to EY, Indivior, Mink, Invo, SafeCor Pharmaceutical Companies
    Brian Bronk
    Brian Bronk, Head of Business Development, Neurology, Rare Diseases, Technology Platforms and R&D Transactions Partnering - Sanofi
    Julie Rozenblyum
    Julie Rozenblyum, Senior Vice President, Business Development - BMS
  8. Capabilities for Advanced Biomanufacturing: Enhancing opportunities and meeting challenges for global access
    BioProcess Theater BioProcess Theater
    Rob Welsh
    Rob Welsh, VP-Biopharma Production Solutions - Avantor
    Ilya Goldberg
    Ilya Goldberg, Chief Science Officer - ViQi
    Craig Vincze
    Craig Vincze, Vice President and Co-founder - Alphinity
    Flaka Radoniqi
    Flaka Radoniqi, Principal Scientist, Pivotal Biologics Drug Substance Technologies - Amgen
  9. Emerging Technologies Fostering Biotech Innovation Globally
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
    Falk Ehmann
    Falk Ehmann, Head of Innovation and Development Accelerator (IDeA) - European Medicines Agency (EMA)
    Blythe Adamson
    Blythe Adamson, Senior Principal Scientist, Head of Outcomes Research - Flatiron Health
    Carmen Laplaza-Santos
    Carmen Laplaza-Santos, Head of Unit Health Innovations and Ecosystems in Directorate General on Research and Innovation - European Commission
    Robert Schröder
    Robert Schröder, Head of Sector External Communication (EISMEA) - European Innovation Council
    Mahesh Yadav
    Mahesh Yadav, Distinguished Scientist - Genentech
    Ferenc Marofka
    Ferenc Marofka - European Commission
  10. Fireside Chat
    Fireside Chat with Nina Kjellson, General Partner, Canaan Partners
    Fireside Chat
    • Business Development and Finance
    30DE
    Allison DeAngelis
    Allison DeAngelis, Reporter - STAT News
    Nina Kjellson
    Nina Kjellson, General Partner - Canaan Partners
  11. Fireside Chat
    Fireside Chat with Stephen Quake, Head of Science, Chan Zuckerberg Initiative
    Fireside Chat
    • Next Generation Biotherapeutics
    25ABC
    Jonathan Wosen
    Jonathan Wosen, West Coast Biotech & Life Sciences Reporter - STAT
    Steve Quake
    Steve Quake, Head of Science - Chan Zuckerberg Initiative
  12. Forging New Pathways to Reimbursement for Digital Therapeutics: Considerations for Payer Coverage
    Breakout Session
    • AI and Digital Health
    24BC
    Brigit Kyei-Baffour
    Brigit Kyei-Baffour, Principal - Avalere
    Jon Campbell
    Jon Campbell, Chief Science Officer - National Pharmaceutical Council
    Dirk Soenksen
    Dirk Soenksen, Co-founder and CEO - Ceresti Health
    Beth Rogozinski
    Beth Rogozinski, CEO - Oncoustics
    Chris Koch
    Chris Koch, CEO - LeGen Medicial Devices
  13. Global Policy Perspectives on the Next Generation of Rare Disease Medicines
    Breakout Session
    • Orphan and Rare Disease
    28ABCDE

    merck logo

    Jannie Oosthuizen
    Jannie Oosthuizen, President, Merck Human Health U.S. - Merck
    Karin Hoelzer
    Karin Hoelzer, Senior Director, Policy and Regulatory Affairs - National Organization for Rare Disorders (NORD)
    Durhane Wong-Rieger
    Durhane Wong-Rieger, President & CEO - Canadian Organization for Rare Disorders (CORD)
    Ryan MacFarlane
    Ryan MacFarlane, Vice President - Access Partnership
    His Excellency Mansoor Al Mansoori
    His Excellency Mansoor Al Mansoori, Abu Dhabi Executive Council Member and Chairman of the Department of Health - Abu Dhabi
  14. Let’s Go STEDI: Moving Beyond QALY’s to Understand the True Value of Antimicrobials and Vaccines
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Ted Buckley
    Ted Buckley, Vice President, Government Affairs - Shionogi
    John Rex
    John Rex, Chief Medical Officer - F2G
    Scott Johnson
    Scott Johnson, CEO/Founder - Medicus Economics
    Ella Balasa
    Ella Balasa, Patient Expert - Balasa Consulting
  15. Longevity Therapeutics Enter Biopharma Mainstream
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Brian Gormley
    Brian Gormley, Reporter - Wall Street Journal
    Marco Quarta
    Marco Quarta, Founder and CEO - Rubedo Life Sciences
    Robert Gould
    Robert Gould, Operating Partner - Khosla Ventures
    Simone Fantaccini
    Simone Fantaccini, Chief Scientific Officer & Head of Medical Affairs - Novartis
    Cristina Ghenoiu
    Cristina Ghenoiu, Investor - Mubadala Capital
    Hanadie Yousef
    Hanadie Yousef, Chief Executive Officer and Co-Founder - Juvena Therapeutics
  16. Patients Wait Less: Streamlining Regulatory Pathways for Cell/Gene Therapies in Asia-Pacific Region
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    Wallace Lin
    Wallace Lin, Secretary-General - Taiwan BIO
    Yueh-Ping Liu
    Yueh-Ping Liu, Director-General, Department of Medical Affairs - Ministry of Health and Welfare of Taiwan
    Chia-Hua (Maggie) Ho
    Chia-Hua (Maggie) Ho, Chief Operating Officer - Amarex Taiwan, LLC
    Joseph Damond
    Joseph Damond, Chair, Global Life Sciences - Crowell & Moring International LLC
    Yoshiaki Maruyama
    Yoshiaki Maruyama, Review Director at the Office of Cellular and Tissue-based Products - PMDA
  17. Triastek, Inc.
    Company Presentation
    • Other
    Company Presentation Theater 4
    Yulian Zhang
    Yulian Zhang, VP of Global BD - Triastek, Inc.
  18. Vasomune Therapeutics Inc
    Company Presentation
    • Respiratory
    Company Presentation Theater 3
    BRIAN JAHNS
    BRIAN JAHNS, President & Chief Operating Officer - Vasomune Therapeutics inc
3:15 PM – 3:30 PM
(PST)
  1. Artax Biopharma
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Christopher VanDeusen
    Christopher VanDeusen, Chief Scientific Officer - Artax Biopharma
  2. Inhalon Biopharma, Inc.
    Company Presentation
    • Respiratory
    Company Presentation Theater 3
    John Whelan
    John Whelan, President, CEO - Inhalon, Biopharma, Inc.
  3. Moonwalk Biosciences, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Alex Aravanis
    Alex Aravanis, CEO - Moonwalk Biosciences
  4. Rejuvenate Biomed
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Ann Belien
    Ann Belien, Founder & CEO - Rejuvenate Biomed
3:30 PM – 3:45 PM
(PST)
  1. Avistone Biotechnology
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    David Chung
    David Chung, Chief Business Officer - Avistone Biotechnology
  2. Ceria Therapeutics, Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    David Jackson
    David Jackson, CEO - Ceria Therapeutics, Inc.
  3. Doloromics
    Company Presentation
    • Pain Management
    Company Presentation Theater 3
    Jackson Brougher
    Jackson Brougher, Chief Science Officer - Doloromics
  4. PlantPharm Biomed, Ltd
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Richard Matner
    Richard Matner, President and Chief Strategy Officer - PlantPharm Biomed, Ltd
3:45 PM – 4:00 PM
(PST)
  1. Avery Therapeutics, Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Jordan Lancaster
    Jordan Lancaster, Chief Executive Officer - Avery Therapeutics, Inc.
  2. BTB Therapeutics
    Company Presentation
    • Pain Management
    Company Presentation Theater 3
    Takashi Kiyoizumi
    Takashi Kiyoizumi, CFO - BTB Therapeutics
  3. GeoVax Labs, Inc.
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    David Dodd
    David Dodd, Chairman & CEO - GeoVax Labs, Inc.
  4. Predictive Oncology
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Raymond Vennare
    Raymond Vennare, Chief Executive Officer - Predictive Oncology
4:00 PM – 4:15 PM
(PST)
  1. Investissement Québec International
    Global Innovation Hub 5A
    Georges Ged
    Georges Ged, Senior Director Foreign Direct Investment - Life Sciences & Health Technologies - Investissement Québec International
  2. Likarda, Inc
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Stella Vnook
    Stella Vnook, CEO - Likarda
  3. Shanghai Novamab Biopharmaceuticals Co., Ltd.
    Company Presentation
    • Immunology
    Company Presentation Theater 2
    Yakun Wan
    Yakun Wan, CEO - Shanghai Novamab Biopharmaceuticals Co., Ltd.
  4. Virpax Pharmaceuticals, Inc.
    Company Presentation
    • Pain Management
    Company Presentation Theater 3
    Gerald Bruce
    Gerald Bruce, Chief Executive Officer - Virpax Pharmaceuticals Inc.
  5. VSPharmTech
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    HO YUN NAM
    HO YUN NAM, General Manager - VSPharmTech
4:15 PM – 5:15 PM
(PST)
  1. Agile Biologics Development and Manufacturing Strategies to Meet Market Demand
    Breakout Session
    • Business Development and Finance
    30DE
    thermofisher scientific
    Paul Jorjorian
    Paul Jorjorian, Vice President & General Manager, Biologics, Pharma Services - Thermo Fisher Scientific
    Glen Campbell
    Glen Campbell, Vice President, Head of External Operations - Vir Biotechnology
    Michael Deperro
    Michael Deperro, SVP, Corporate Development - Rezolute Inc
    Adam Pfeiffer
    Adam Pfeiffer, Vice President - Farma Project
  2. Altering the Regulatory Ecosystem for Pediatric Clinical Programs: Intended and Unintended Consequences
    Breakout Session
    • Regulatory Innovation
    31C
    Catherine Lee
    Catherine Lee, Associate Director, Global Regulatory Policy and Intelligence - Johnson & Johnson
    Laurie Conklin
    Laurie Conklin, Senior Director, Pediatric Development - Johnson & Johnson
    Dionna Green
    Dionna Green, Director, Office of Pediatric Therapeutics - FDA
    Thomas Miller
    Thomas Miller, Global Head, Acute, Chronic & Pediatric Disease Nucleus - Bayer
  3. Avoid the Cycle of “Panic and Neglect": How Ongoing Commitment to Innovative Partnerships Futureproofs Against the Next Pandemic
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Paul Friedrichs
    Paul Friedrichs, Maj. Gen. (ret), Deputy Assistant to the President - Director of the Office of Pandemic Preparedness and Response at the White House
    Georges Benjamin
    Georges Benjamin, Executive Director - American Public Health Association
    Laurent Muschel
    Laurent Muschel, Acting Director General - European Commission, Health Emergency Preparedness and Response Authority (HERA)
    Emma Wheatley
    Emma Wheatley, Director, Access and Private Partnerships - CEPI
    Dawn O'Connell
    Dawn O'Connell, Assistant Secretary for Preparedness and Response (ASPR), HHS - U.S. Department of Health and Human Services
    Kelly Cappio
    Kelly Cappio, Vice President, Global Policy and Government Affairs - Novavax
  4. Creative Structures for Keeping Innovation Alive After the Deal
    Breakout Session
    • Business Development and Finance
    29AB
    Oren Livne
    Oren Livne, Partner - Baker McKenzie
    Gavin Liu
    Gavin Liu, Senior Director, Legal Strategic Transactions - Astellas
    Deepa Talpade
    Deepa Talpade, Vice President, Head BD&L and Alliance Mgmt., Oncology - Bayer
    Maria Nichol
    Maria Nichol, Chief Business Officer - Artax Biopharma
    Ellen Lubman
    Ellen Lubman, Chief Business Officer - Werewolf Therapeutics
    Casarine Chong
    Casarine Chong, Senior Vice President, Deputy General Counsel, Transactions - Bristol Myers Squibb
  5. Epion Therapeutics
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Michael Webb
    Michael Webb, President & CEO - Epion Therapeutics, Inc.
  6. Fireside Chat
    Fireside Chat with Matt Gline, CEO, Roivant Sciences
    Fireside Chat
    • Business Development and Finance
    25ABC
    Michelle Davis
    Michelle Davis, M&A Reporter - Bloomberg News
    Matt Gline
    Matt Gline, Chief Executive Officer - Roivant Sciences
  7. From Patients to Partners: Patient Advocacy and Biotech Collaborate to Accelerate Innovation
    Breakout Session
    • Patient Advocacy
    26A
    Anthony Mancini
    Anthony Mancini, EVP & Chief Operating Officer - Genmab
    Meghan Gutierrez
    Meghan Gutierrez, CEO - Lymphoma Research Foundation
    Portia Badham
    Portia Badham, Patient Advocate and Marketing/Communications Consultant
    Sabine Haubenreisser
    Sabine Haubenreisser, Principal Scientific Administrator, Stakeholders and Communications Division - European Medicines Agency (EMA)
  8. Gun Violence Prevention: A Case Study in Passing Meaningful Policies in a Hyper Partisan Era
    Special Program
    • Regulatory Innovation
    28ABCDE
    Josh Horwitz
    Josh Horwitz, Co-director - Johns Hopkins Center for Gun Violence Solutions
    Angus McQuilken
    Angus McQuilken, co-founder - Life Sciences to End Gun Violence Epidemic
    Jen Pauliukonis
    Jen Pauliukonis, Director of Policy and Programming - Johns Hopkins Center for Gun Violence Solutions
    Traci Murphy
    Traci Murphy, Executive Director - Delaware Coalition Against Gun Violence and Coalition For A Safer Delaware
  9. Innovation Passport: Emerging Opportunities for Company Growth in Global Markets
    Breakout Session
    • Business Development and Finance
    32AB
    Susie Harborth
    Susie Harborth, Chief Business Officer - Breakthrough Properties
    Bernard Parker
    Bernard Parker, Chief Business Officer - Shanghai Pharma Biotherapeutics USA, Inc.
    Avi Spier
    Avi Spier, Executive Director Business Development and Licensing - Novartis
    Kristen Albright
    Kristen Albright, CEO - Prokarium
    Wen Qi Ho
    Wen Qi Ho, Therapeutics Lead - ClavystBio
  10. Investors' Perspectives: Digital Health Trends and Investment Thesis in 2024 and Beyond
    Breakout Session
    • AI and Digital Health
    24BC
    Josh Seidenfeld
    Josh Seidenfeld, Partner and Chair, Digital Health - Cooley LLP
    Sourav Kole
    Sourav Kole, Managing Director - Dolby Family Ventures
    Mara Aspinall
    Mara Aspinall, Partner - Illumina Ventures
    Christina DelloRusso
    Christina DelloRusso, Partner - LRVHealth
    Matt Blum
    Matt Blum, Principal - Cigna Ventures
  11. Quality Standards for Final Preparation of CGT Product at Point of Care (POC)
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Maria Amaya
    Maria Amaya, Lead External Advocacy, Quality Policy and Advocacy - Genentech, A member of the Roche Group
    Lesbeth Rodriguez
    Lesbeth Rodriguez, Director, Regulatory Affairs, Policy and Innovation - Bayer
    Maria Sørensen
    Maria Sørensen, Specialist, RA CMC Lead - Novo Nordisk
    Steffen Thirstrup
    Steffen Thirstrup, Chief Medical Officer - European Medicines Agency (EMA)
    Heather Lombardi
    Heather Lombardi, Director, Office of Cellular Therapy and Human Tissue - FDA
  12. Recce Pharmaceuticals
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    James Graham
    James Graham, CEO - Recce Pharmaceuticals
  13. Reveal Pharma
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Srini Mukundan
    Srini Mukundan, Medical Director - Reveal Pharmaceuticals Inc
  14. Unlocking Biotech Growth: Hong Kong as the Gateway to Global Markets
    Breakout Session
    • Asia-Pacific Opportunities
    30ABC
    hkstp
    Albert Wong
    Albert Wong, CEO - Hong Kong Science and Technology Parks Corporation
    Grace Lau
    Grace Lau, Head, Institute for Translational Research - Hong Kong Science and Technology Parks Corporation
    Andy Wong
    Andy Wong, Head of Innovation and Technology - Invest Hong Kong
    Michael Chen
    Michael Chen, CEO & Co-founder - Great Bay Bio Limited
    Gaobo Zhou
    Gaobo Zhou, Chief Investment Officer - Simcere Pharmaceutical Group Limited
    Vicky Qu
    Vicky Qu, Senior Vice President and Chief of Staff - BioMap
  15. Unlocking Success to Biotech Global Expansion: A Stepwise Game Plan for International Launch
    Breakout Session
    • Emerging Opportunities in Global Markets
    26B
    Eduardo Schur
    Eduardo Schur, US Health Sciences & Wellness Commercial Strategy and R&D Lead - EY (Ernst & Young)
    Tolga Tanguler
    Tolga Tanguler, CCO - Alnylam Pharmaceuticals
    Russell Cox
    Russell Cox, President & CEO - Epirium Bio
    Robert LaCaze
    Robert LaCaze, CEO - Mnemo Therapeutics
    Ger Brophy
    Ger Brophy, Chair of the Scientific Advisory Board and retiring EVP Biopharma Production - Avantor
    Jérôme Revole
    Jérôme Revole, Managing Director Healthcare and Lifesciences - Business France North America
  16. Use of AI in mRNA: The New Revolution?
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Andy French
    Andy French, Director, Data & AI - CGI
    Mathieu Blanchette
    Mathieu Blanchette, Director - McGill University
    Christian Barrow
    Christian Barrow, Executive Director - J.P. Morgan
    Petrina Kamya
    Petrina Kamya, Vice President and Global Head of AI Platforms, Insilico Medicine - President, Insilico Medicine Canada
    Andrew Giessel
    Andrew Giessel, Executive Director - Moderna
    Ashoka Madduri
    Ashoka Madduri, Head of Scientific Strategy and CI - mRNA CoE, Sanofi
  17. Varda Space Industries, Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Mark Herbert
    Mark Herbert, Vice President, Business Development - Varda Space Industries, Inc.
4:30 PM – 4:45 PM
(PST)
  1. Concerto Biosciences
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Cheri Ackerman
    Cheri Ackerman, CEO & Cofounder - Concerto Biosciences
  2. Japan - Global Innovation Hub
    Global Innovation Hub 5A
    Mikiro Suga
    Mikiro Suga, Senior Coordinator, Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau - Ministry of Health, Labour and Welfare of Japan (MHLW)
    Hirokazu Shimoda
    Hirokazu Shimoda, Director, Bio-Industry Division, Commerce and Service Industry Policy Group - Ministry of Economy, Trade and Industry (METI)
    Nobutaka Maekawa
    Nobutaka Maekawa, Executive Vice President - Japan External Trade Organization (JETRO)
  3. Neuracle Genetics
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Sunwoo Kim
    Sunwoo Kim, Head of Business Development - Neuracle Genetics
  4. QBiotics Group Limited
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Victoria Gordon
    Victoria Gordon, Executive Director Strategic Alliances & Investor Relations - QBiotics Group Limited
  5. TechInvention Lifecare Pvt Ltd
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Syed Ahmed
    Syed Ahmed, Director & CEO - Techinvention Lifecare Private Limited
4:45 PM – 5:00 PM
(PST)
  1. Breye Therapeutics
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Ulrik Mouritzen
    Ulrik Mouritzen, CEO - Breye Therapeutics
  2. Centivax, Inc.
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Jacob Glanville
    Jacob Glanville, Founder & CEO - Centivax
  3. KAHR Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Yaron Pereg
    Yaron Pereg, CEO - Kahr Medical Ltd.
  4. Talus Bio
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Alex Federation
    Alex Federation, Co-Founder and CEO - Talus Bio
5:00 PM – 5:15 PM
(PST)
  1. Boryung Co., Ltd.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Bong Seog Kim
    Bong Seog Kim, CTO - BORYUNG CO., LTD.
  2. Cytotheryx
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    John Swart
    John Swart, CEO - Cytotheryx
  3. Lynthera Corporation
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 3
    Jeff Yang
    Jeff Yang, President & CEO - Lynthera Corporation
5:15 PM – 5:30 PM
(PST)
  1. ELEM Biotech
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Christopher Morton
    Christopher Morton, CEO - ELEM Biotech
  2. Kernal Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    YUSUF ERKUL
    YUSUF ERKUL, CEO - Kernal Biologics
  3. Miracure Biotechnology
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Xiaolin Li
    Xiaolin Li, FOUNDER/CEO - Miracure Biotechnology
  4. Pending AI
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    David Cardoso
    David Cardoso, Vice President, Business Development and Strategy - Pending AI
7:00 PM – 9:00 PM
(PST)
  1. Welcome Reception
    Reception Rady Shell at Jacobs Park
9:00 AM – 10:30 AM
(PST)
  1. Main Stage Opening Program
    Main Stage Program Ballroom 20
    Ted Love
    Ted Love, Chair - BIO Board of Directors
    Aaron Lazar
    Aaron Lazar, Actor, Singer, and Advocate
  2. The Convergence of Entrepreneurship and Innovation featuring Viola Davis
    Main Stage Program Ballroom 20
    Brooke Baldwin
    Brooke Baldwin, TV host, award-winning journalist and bestselling author
    Viola Davis
    Viola Davis, Award-Winning Actress, Producer, and New York Times Best-Selling Author
10:30 AM – 11:00 AM
(PST)
  1. ARC Medical Inc.
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    Andrew Rae
    Andrew Rae, Consultant to ARC - Financing and Business Development - ARC Medical Inc.
  2. Company Presentations Tuesday
    Company Presentation Session Company Presentation Theaters
    johnson and johnson
  3. Elanco Animal Health
    Company Presentation
    • Animal Health Products
    Company Presentation Theater 2
    Steve Nanchen
    Steve Nanchen, Snr Director - Elanco Animal Health
  4. Entero Therapeutics formerly First Wave BioPharma
    Company Presentation
    • Gastrointestinal
    Company Presentation Theater 4
    James Sapirstein
    James Sapirstein, Chairman and CEO - First Wave BioPharma, Inc.
  5. Overcoming Development, Scale Up and Commercial Production Challenges for Novel Modalities
    BioProcess Theater BioProcess Theater
  6. Welcome Session: BioProcess Insider
    BioProcess Theater Session BioProcess Theater
    Dan Stanton
    Dan Stanton, Founder and Managing Editor - BioProcess Insider
  7. Zambon Biotech SA
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Cibele Sabido David
    Cibele Sabido David, Head of Business Development - Zambon Biotech
10:45 AM – 11:00 AM
(PST)
  1. Auxergen, Inc.
    Company Presentation
    • Food and Agriculture
    Company Presentation Theater 2
    Gregory Contreras
    Gregory Contreras, C.E.O. - Auxergen, Inc
  2. Pirouette Medical Inc.
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    Conor Cullinane
    Conor Cullinane, President, CEO - Pirouette Medical Inc.
  3. Tonix Pharmaceuticals Holding Corp.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Jessica Morris
    Jessica Morris, Chief Operating Officer - TONIX Pharmaceuticals
  4. YourChoice Therapeutics
    Company Presentation
    • Reproductive/Sexual Health
    Company Presentation Theater 4
    Akash Bakshi
    Akash Bakshi, CEO - YourChoice Therapeutics
11:00 AM – 11:30 AM
(PST)
  1. AI's Trial by Fire: Experimental Validation in Drug Discovery
    Breakout Session
    • AI and Digital Health
    24BC
    Nitya Sridhar
    Nitya Sridhar - Power
    Martin Akerman
    Martin Akerman, Co-founder and CTO - Envisagenics
    Alex Zhavoronkov
    Alex Zhavoronkov, Founder and CEO - InSilico Medicine
    Michael Bemben
    Michael Bemben, Director, Data Science and External Innovation - Johnson & Johnson
    Etai Jacob
    Etai Jacob, Senior Director, Head of Data Science and AI, Early Oncology - AstraZeneca
    Stacie Calad Thomson
    Stacie Calad Thomson, Vice Chairperson - Alliance for AI in Healthcare (AAIH)
  2. BioLattice Ophthalmics, Inc.
    Start-Up Stadium Session
    • Ophthalmology
    5B
    Amelia Zellander
    Amelia Zellander, CEO - BioLattice Ophthalmics, Inc.
  3. Black Canyon Bio
    Start-Up Stadium Session
    • Oncology
    5B
    Ken Carter
    Ken Carter
  4. Brick-by-Brick: Building a Biotech from Foundation Up with Venture Investor Company Formation
    Breakout Session
    • Business Development and Finance
    26B
    Allison DeAngelis
    Allison DeAngelis, Reporter - STAT News
    Ann Lee-Karlon
    Ann Lee-Karlon, Chief Executive Officer and President - EpiBiologics
    Amy Liu
    Amy Liu, Investor - Mubadala Capital
    Mitchell Mutz
    Mitchell Mutz, Entrepreneur Partner - Vivo Capital
    Sanjay Mistry
    Sanjay Mistry, Vice President - Johnson & Johnson Innovation
  5. Build Your Product Pipeline with Non-Dilutive Federal Resources
    Breakout Session
    • Business Development and Finance
    29AB
    Stephanie Fertig
    Stephanie Fertig, Director, NIH Small Business Program - National Institutes of Health (NIH)
    Elaine Haynes
    Elaine Haynes, President and CEO - KaloCyte, Inc.
    Julius Korley
    Julius Korley, Associate Vice President, Office of Economic Innovation and Partnerships - University of Delaware
    Meghan Wood
    Meghan Wood, Managing Director - New York Blood Center Ventures
    Anna Zornosa-Heymann
    Anna Zornosa-Heymann, Advisor, entrepreneur, investor Entrepreneur in Residence, National Institutes of Health (NIH) Advisor, Ignite Health Accelerator - Astia Fund and Hera Biotech
  6. Building a Bioscience Economy Through Supportive State Legislation: A Discussion with State Legislators from California, Massachusetts, and the Midwest
    Special Program
    • Regulatory Innovation
    29C
    Pete Pellerito
    Pete Pellerito, Senior Policy Adviser Federal/State Economic Development & Technology Transfer Lead - BIO
    Cottie Petrie-Norris
    Cottie Petrie-Norris, California Assemblywoman - 73rd Assembly District – Costa Mesa, Irvine and Tustin
    Chris Ward
    Chris Ward, California Assemblymember - 8th Assembly District - San Diego and El Cajon
    Jordan Rasmusson
    Jordan Rasmusson, Minnesota Senator
    John Lawn
    John Lawn, Massachusetts Representative - 10th District - Middlesex
  7. CELLeBRAIN, Ltd
    Start-Up Stadium Session
    • Oncology
    5B
    Haeyoung Suh-Kim
    Haeyoung Suh-Kim, CEO - CELLeBRAIN
  8. Daré Bioscience
    Company Presentation
    • Reproductive/Sexual Health
    Company Presentation Theater 4
  9. Super Session
    Decoding Biopharma's Public Image: Navigating 2024 Election Dynamics
    Super Session
    • Next Generation Biotherapeutics
    28ABCDE
    Genentech logo
    Fritz Bittenbender
    Fritz Bittenbender, Senior Vice President - Genentech
    Kathleen Rice
    Kathleen Rice
    Greg Walden
    Greg Walden, Former Chair - US House Energy and Commerce Committee
    Neil Newhouse
    Neil Newhouse, Partner and Co-Founder - Public Opinion Strategies
  10. FDA Townhall
    Special Program
    • Regulatory Innovation
    25ABC
    Steve Berman
    Steve Berman, Deputy Vice President, Science and Regulatory Affairs Strategy - Biotechnology Innovation Organization (BIO)
    Patrizia Cavazzoni
    Patrizia Cavazzoni, Director, Center for Drug Evaluation and Research - FDA
    Peter Marks
    Peter Marks, Director, Center for Biologics Evaluation and Research (CBER) - U.S. Food and Drug Administration
  11. FELIQS
    Start-Up Stadium Session
    • Ophthalmology
    5B
    Kenichiro Kuninobu
    Kenichiro Kuninobu, Co-founder and CEO - Feliqs
  12. Immunic Therapeutics
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Jessica Breu
    Jessica Breu, Vice President, Investor Relations and Communications - Immunic Therapeutics
  13. In and Out of This World: Partnering with Federal Labs
    Breakout Session
    • Business Development and Finance
    32AB
    Vladimir Popov
    Vladimir Popov, Chief Innovation Officer - Frederick National Laboratory for Cancer Research
    Edward Diehl
    Edward Diehl, Commercialization Officer - U.S. Army Medical Research and Development Command
    Tara Kirby
    Tara Kirby, Director of the Office of Technology Transfer - National Institutes of Health
    Michael Roberts
    Michael Roberts, Chief Scientific Officer - International Space Station National Laboratory
    Gillian Fenton
    Gillian Fenton, Vaccines Legal Operations - GSK
    Lisa Thomas Read
    Lisa Thomas Read, Vice President, Research and Development - Amivas (US), LLC
  14. Italian Trade Agency
    Global Innovation Hub 5A
    Marco Cito
    Marco Cito, Head of the Foreign Investments Attraction Department - Italian Trade Agency
  15. Jaan Biotherapeutics
    Start-Up Stadium Session
    • Cardiovascular
    5B
    Bhawanjit Brar
    Bhawanjit Brar, Chief Executive Officer - Jaan Biotherapeutics
  16. Mabswitch Inc
    Start-Up Stadium Session
    • Oncology
    5B
    Yemi Onakunle
    Yemi Onakunle, CEO - MabSwitch Inc
  17. Navigating the Future of Cell and Gene Therapy: Strategies for Innovation, Collaboration, and Market Success
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    30ABC
    cencora
    Lung-I Cheng
    Lung-I Cheng, Vice President, Cell and Gene Therapy - Cencora
    Irene Agodoa
    Irene Agodoa, Senior Vice President, Head of Medical Affairs - Orca Bio
    Adriana Herrera
    Adriana Herrera, Chief Executive Officer - Pierre Fabre Pharmaceuticals
    Brad Martin
    Brad Martin, Vice President, Head of Market Access and Trade - Neurotech Pharmaceuticals
    Robert Sexton
    Robert Sexton, former Senior Vice President, Strategy & Program Execution - Mustang Bio
  18. New Pain Therapeutics: Strategies for Innovation, Investment, and Collaboration
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Hernan Bazan
    Hernan Bazan, CEO & Co-Founder - South Rampart Pharma, Inc.
    Emily Caporello
    Emily Caporello, Program Director, Division of Translational Research - NINDS, NIH
    Paige Cramer Lacatena
    Paige Cramer Lacatena, Director Business Development and Licensing, HQ Neurology - Merck
    Ana Moreno
    Ana Moreno, CEO and Founder - Navega Therapeutics
    Paul Mieyal
    Paul Mieyal, Managing Director - Outcome Capital, LLC
    Todd Bertoch
    Todd Bertoch, Chief Executive Officer at JBR Clinical Research - CenExel
  19. Orakl Oncology
    Start-Up Stadium Session
    • Oncology
    5B
    Fanny Jaulin
    Fanny Jaulin, Co-founder and CEO - Orakl Oncology
  20. SLAM BioTherapeutics, Inc.
    Start-Up Stadium Session
    • Oncology
    5B
    Steven Potts
    Steven Potts
  21. Spurring Biotech Innovation And Access Across the Globe: A High- Level Discussion
    Breakout Session
    • Emerging Opportunities in Global Markets
    30DE
    Marwan Abdulaziz Janahi
    Marwan Abdulaziz Janahi, Senior Vice President - Dubai Science Park
    Mansoor Al Mansoori
    Mansoor Al Mansoori, Chairman, Abu Dhabi Department of Health - UAE
    Lise Alter
    Lise Alter, General Manager - French Health Innovation Agency
  22. Start-Up Stadium Tuesday Morning
    Start-Up Stadium 5B
  23. Strengthening of the Clinical Trials Environment in Europe Under the Accelerating Clinical Trials (ACT EU) Initiative
    Breakout Session
    • Clinical Trials Innovations
    31C
    Laura Pioppo
    Laura Pioppo, ACT EU Programme manager - European Medicines Agency (EMA)
    Claire Skentelbery
    Claire Skentelbery, Director General - EuropaBio
    Carmen Laplaza-Santos
    Carmen Laplaza-Santos, Head of Unit Health Innovations and Ecosystems in Directorate General on Research and Innovation - European Commission
    Nathalie Seigneuret
    Nathalie Seigneuret, Senior Scientific Project Manager - Innovative Health Initiative (IHI)
    Thomas Bols
    Thomas Bols, Head of Government Affairs and Patient Engagement, EMEA & APAC - PTC Therapeutics
  24. Targeting the Brain: How Biotech is Uncovering the Biology of Brain Disease for Precision Neurotherapeutics
    Breakout Session
    • Brain Health
    26A
    Alaa Halawa
    Alaa Halawa, Executive Director and Head of Healthcare, US Ventures - Mubadala Capital
    Carol Suh
    Carol Suh, Co-founder & Chief Operating Officer - Neumora
    Joanne Taylor
    Joanne Taylor, Senior Vice President, Research - Gain Therapeutics
    Richard Shea
    Richard Shea, CEO - Basking Biosciences
    Craig Thompson
    Craig Thompson, CEO - Cerevance
  25. Vaxxas
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    David Hoey
    David Hoey, Chief Executive Officer - Vaxxas
  26. What is Needed for Gene Therapy in the Future and How Close Are We?
    Session
    Larry Foreman
    Larry Foreman, CEO - CHO-Plus
  27. Zoetis
    Company Presentation
    • Animal Health Products
    Company Presentation Theater 2
    Stephane Shu Kin So
    Stephane Shu Kin So, Director, External Innovation - Zoetis
11:15 AM – 11:30 AM
(PST)
  1. Bionomics Ltd
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Spyros Papapetropoulos
    Spyros Papapetropoulos, President and CEO - Bionomics Ltd
  2. Boehringer Ingelheim Animal Health
    Company Presentation
    • Animal Health Products
    Company Presentation Theater 2
    Kate Christmas
    Kate Christmas, Director, Strategic Partnering AH - Boehringer Ingelheim
  3. Eydisbio Inc.
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 4
    Scott Scarneo
    Scott Scarneo, Selective small molecule targeting of TAK1/TNF signaling in systemic sclerosis - EydisBio Inc.
  4. ICEX SPAIN TRADE & INVESTMENT
    Global Innovation Hub 5A
    Maria J. Fernandez
    Maria J. Fernandez, Trade Commissioner - Trade Commission of Spain in Chicago - ICEX Spain Trade & Investment
  5. Know Labs, Inc.
    Company Presentation
    • Medical Devices
    Company Presentation Theater 3
    Leo Trautwein
    Leo Trautwein, Chief Commercial Officer - Know Labs
11:30 AM – 1:00 PM
(PST)
  1. Boehringer Ingelheim
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Scott DeWire
    Scott DeWire, US Head, Business Development & Licensing - Boehringer Ingelheim
  2. Carcinotech
    Company Presentation
    • Oncology
    Company Presentation Theater 3
    Ishani Malhotra
    Ishani Malhotra, Founder & CEO - Carcinotech
  3. Lumos Pharma
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 4
    Aaron Schuchart
    Aaron Schuchart, Chief Business Officer - Lumos Pharma
  4. Neuren Pharmaceuticals
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Jon Pilcher
    Jon Pilcher, CEO - Neuren Pharmaceuticals
  5. Polish Investment and Trade Agency
    Global Innovation Hub 5A
    Zuzanna Kobrzynski
    Zuzanna Kobrzynski, Polish Investment and Trade Agency - Polish Investment and Trade Agency
  6. Premier & General Attendee Lunch
    Session Sails Pavilion
11:40 AM – 12:00 PM
(PST)
  1. What unseen trouble lies within your processes? Increasing confidence in preventing microbial contamination with efficient decontamination in Biopharmaceutical and ATMP manufacturing
    BioProcess Theater Session
    Madison Hoal
    Madison Hoal, Senior Global Technical Consultant - Ecolab Life Sciences
11:45 AM – 12:00 PM
(PST)
  1. FibroBiologics Clinical Update
    Company Presentation
    • Regenerative Medicine
    Company Presentation Theater 3
    Hamid Khoja
    Hamid Khoja, Chief Scientific Officer - FibroBiologics
  2. ImmunoForge Co., Ltd.
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 4
    Jim Ballance
    Jim Ballance, Chief Technology Officer - ImmunoForge Co. Ltd.
  3. Swiss Biotech Association
    Global Innovation Hub 5A
    Michael Altorfer
    Michael Altorfer, CEO - Swiss Biotech Association
  4. Transcend Therapeutics
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Blake Mandell
    Blake Mandell, CEO - Transcend Therapeutics
12:00 PM – 12:15 PM
(PST)
  1. ADvantage Therapeutics Inc.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Achim Schneeberger
    Achim Schneeberger
  2. BioProcess Insider Interviews: Samsung Biologics
    BioProcess Theater Session BioProcess Theater
    Kevin Sharp
    Kevin Sharp, Senior Vice President, Head of Global Sales - Samsung Biologics
  3. Genentech, a Member of the Roche Group
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Ajay Narasimha
    Ajay Narasimha, Executive Director, Immunology, Infectious Disease, Cardiovascular/Metabolism, Pharma Partnering - Genentech
  4. Hong Kong Science & Technology Parks Corporation
    Global Innovation Hub 5A
    Grace Lau
    Grace Lau, Head, Institute for Translational Research - Hong Kong Science and Technology Parks Corporation
  5. Percheron Therapeutics Limited
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 4
    James Garner
    James Garner, Chief Executive Officer - Percheron Therapeutics Limited
  6. Rejuvenation Technologies
    Company Presentation
    • Regenerative Medicine
    Company Presentation Theater 3
    John Ramunas
    John Ramunas, CEO & Founder - Rejuvenation Technologies
12:10 PM – 12:20 PM
(PST)
  1. BioProcess Insider Interviews: Curia Biologics
    BioProcess Theater Session
    Steve Lavezoli
    Steve Lavezoli, VP, Biologics Division - Curia Biologics
12:15 PM – 1:30 PM
(PST)
  1. Avanzanite Bioscience
    Company Presentation
    • Orphan and Rare Disease
    Company Presentation Theater 4
    Eva Cruz de Castro
    Eva Cruz de Castro, Chief Business Development Officer - Avanzanite Bioscience
  2. GSK
    Company Presentation
    • Multiline Global Biopharma
    Company Presentation Theater 2
    Jeannie Rojas
    Jeannie Rojas, Senior Director - Business Development, Transactions - GSK
  3. inSoma Bio
    Company Presentation
    • Regenerative Medicine
    Company Presentation Theater 3
    Stefan Roberts
    Stefan Roberts, CEO - InSoma Bio
  4. Silver Creek Pharmaceuticals
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Kris Kuchenbecker
    Kris Kuchenbecker, Chief Science & Technology Officer - Silver Creek Pharmaceuticals
  5. UK Government Department for Business and Trade
    Global Innovation Hub 5A
    Raffaella Harvey
    Raffaella Harvey, Senior Manager, Biopharmaceuticals - Department for Business and Trade
  6. Super Session
    Where to Launch? Expanding Beyond Home and Activating Your Product’s Global Potential
    Super Session
    • Emerging Opportunities in Global Markets
    28ABCDE
    Cencora
    Sandra Anderson
    Sandra Anderson, Senior Vice President - Cencora
    Grant Castor
    Grant Castor, Senior Vice President, Commercial Strategy and Operations - Sentynl Therapeutics, Inc.
    Glenn Pauly
    Glenn Pauly, Chief Commercial Officer - Alzheon
    Peter Radovich
    Peter Radovich, President & Chief Operating Officer - Mirum Pharma
    Joel Prieve
    Joel Prieve, Senior Vice President, Licensing and Mergers & Acquisitions - Outlook Therapeutics
12:20 PM – 1:00 PM
(PST)
  1. The Manufacturing Make vs. Buy Decision for Cell and Gene Therapies: Implications for Overcoming Manufacturing Bottlenecks and Challenges
    BioProcess Theater Session BioProcess Theater
    Stephen Orosz
    Stephen Orosz, Managing Director - BDO
    Adam Haskett
    Adam Haskett, Senior Director (Head of) External Manufacturing - Cargo Therapeutics
    David Fontana
    David Fontana, Chief Operating and Chief Business Officer - Umoja Biopharma
    Heikki Jouttijärvi
    Heikki Jouttijärvi, Senior Vice President, Manufacturing and Supply Chain Management - Adverum Biotechnologies, Inc.
    Brad Stewart
    Brad Stewart, , Market Managing Principal, National Life Sciences Leader - BDO
12:30 PM – 12:45 PM
(PST)
  1. Taiwan BIO
    Global Innovation Hub 5A
    Wallace Lin
    Wallace Lin, Secretary-General - Taiwan BIO
12:45 PM – 1:00 PM
(PST)
  1. Belgian Pavilion
    Global Innovation Hub 5A
    Willem Dhooge
    Willem Dhooge, COO - Flanders.Bio
1:00 PM – 1:30 PM
(PST)
  1. Development of Cell Therapy Products through Global CDMOs
    BioProcess Theater Session
    Vadim Klyushnichenko
    Vadim Klyushnichenko, VP Bio/Pharmaceutical Development & Quality - Calibr-Skaggs Institute for Innovative Medicines
1:30 PM – 2:45 PM
(PST)
  1. Student Program: An Introduction to the Biotechnology Industry
    Special Program
    • Diversity‚ Equity and Inclusion
    29AB
    Pete Pellerito
    Pete Pellerito, Senior Policy Adviser Federal/State Economic Development & Technology Transfer Lead - BIO
    Thomas Miller
    Thomas Miller, Global Head, Acute, Chronic & Pediatric Disease Nucleus - Bayer
    Kollet Koulianos
    Kollet Koulianos, Senior Payer Advisor - Hemophilia Alliance
    Stanley Maloy
    Stanley Maloy, Emeritus Associate VP for Innovation and Professor of Microbiology - San Diego State University
  2. The Ultimate Interface for Drug Discovery: How Spatial Computing and AI Agents are Transforming the Way We Understand Molecules
    BioProcess Theater Session
    Steve McCloskey
    Steve McCloskey, Founder and CEO - Nanome
1:45 PM – 2:30 PM
(PST)
  1. Accelerating the Globalization of Cell and Gene Therapies
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Jennifer Rabin
    Jennifer Rabin, Specialist Leader - Deloitte Consulting LLP
    Shahrukh Hashmi
    Shahrukh Hashmi, Faculty - Mayo Clinic
    Peter Holman
    Peter Holman, VP of Quality - Arsenal Bio
    Robert Hughes
    Robert Hughes, Global Head of Technical Operations - Galapagos
    Kristen Sudol
    Kristen Sudol, Vein to Vein Supply Chain - Johnson & Johnson
    Sumant Ramachandra
    Sumant Ramachandra, CEO - Impact Bio
    Xiaoxi (Sofie) Wei
    Xiaoxi (Sofie) Wei, CEO & Co-Founder - X-Therma
  2. AI/ML is Transforming R&D and Business
    Breakout Session
    • AI and Digital Health
    24BC
    Maude Tessier
    Maude Tessier, Chief Business Officer - Seismic Therapeutic
    Jiye Shi
    Jiye Shi, Vice President - Eli Lilly
    Joe McDonald
    Joe McDonald, Chief Data Officer - Odyssey Therapeutics
    Karen Akinsanya
    Karen Akinsanya, President, R&D - Therapeutics - Schrodinger, Inc.
    Frank Grams
    Frank Grams, Chief Commercial Officer - Partex NV
  3. BlueSphere Bio
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Keir Loiacono
    Keir Loiacono, Chief Executive Officer - BlueSphere Bio
  4. Creative Claiming for Platforms & Products: Designing an IP Strategy to Go Global
    Breakout Session
    • Intellectual Property
    26B
    Tanis Keirstead
    Tanis Keirstead, Partner - Mewburn Ellis
    Malathi Lakshmikumaran
    Malathi Lakshmikumaran, Executive Director and Practice Head - Lakshmikumaran & Sridharan
    Yoon Suk SHIN
    Yoon Suk SHIN, Senior Partner/Patent Attorney - Lee International IP & Law
    Amy Feng
    Amy Feng, Managing Partner - Wu, Feng & Zhang
    Patricia Campbell
    Patricia Campbell, IP Partner - Jones Day
  5. Fireside Chat
    Fireside Chat with Robert A. Bradway, Chairman and Chief Executive Officer, Amgen
    Fireside Chat
    • Business Development and Finance
    25ABC
    John Crowley
    John Crowley, President & CEO - Biotechnology Innovation Organization (BIO)
    Robert Bradway
    Robert Bradway, Chief Executive Officer and Chairman - Amgen
  6. Growth Opportunities from Women’s Health Investments
    Breakout Session
    • Business Development and Finance
    30DE
    Sheila Mikhail
    Sheila Mikhail, Board Member, Women's Health Access Matters; Executive Director - BC Ruckus
    Mary Beth Cicero
    Mary Beth Cicero, Co-Founder and CEO - 3Daughters
    Julia Owens
    Julia Owens, CEO - Verto Therapeutics
    Megan Greenfield
    Megan Greenfield, Partner - McKinsey & Co
  7. How Should Biotechs Plan and Partner with CROs and Other Providers to Deliver Clinical Research and Maximize the Value of their Asset?
    Breakout Session
    • Business Development and Finance
    23BC
    fortrea logo
    Tom Pike
    Tom Pike, Chairman and Chief Executive Officer - Fortrea
    Jennifer Byrne
    Jennifer Byrne, Founder and CEO - Javara
    Michael Norton
    Michael Norton, Senior Advisor - Boston Consulting Group
    Gadi Saarony
    Gadi Saarony, CEO - Advarra
  8. Inimmune Inc.
    Company Presentation
    • Immunology
    Company Presentation Theater 1
    Alan Joslyn
    Alan Joslyn, Chief Executive Officer - Inimmune Inc.
  9. Joining Forces to Accelerate Innovation in Oncology
    Breakout Session
    • Oncology
    30ABC
    Genentech logo
    Mandy Jackson
    Mandy Jackson, Managing Editor (US Commercial News) - Scrip
    Visali Ramanathan
    Visali Ramanathan, Executive Director, Head of Business Development for Oncology - Genentech
    Gregor Fachinger
    Gregor Fachinger, VP, Head of Oncology & Immuno-Oncology Business Development - Merck KGaA
    Susan Graf
    Susan Graf, Biotech Executive, Board Member & Advisor
    Mira Chaurushiya
    Mira Chaurushiya, Senior Partner - Westlake Village BioPartners
  10. Merck
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Grace Han McMahon
    Grace Han McMahon, Associate Vice President and Head of Merck’s BD&L Pacific Innovation Hub - Merck
  11. NIH Support for Minority Health and Health Disparities Focused on Early-Stage Life Science Companies
    Breakout Session
    • Diversity‚ Equity and Inclusion
    31C
    Dave Whelan
    Dave Whelan, Managing Director - Bespoke Strategies
    Michael Banyas
    Michael Banyas, Program Manager - National Institute of Minority and Health Disparities
    Corine Farewell
    Corine Farewell, Director UVM Innovations - University of Vermont
    Anna Lisa Somera
    Anna Lisa Somera, CEO - Rhaeos
    Ke Zhang
    Ke Zhang, Founder and interim CEO - Allerdia Inc.
  12. Promising Advances in Neuroscience: New Molecular Targets and Biomarkers
    Breakout Session
    • Brain Health
    26A
    Hank Safferstein
    Hank Safferstein, Senior Advisor - UPMC Enterprises
    Susanne Ahmari
    Susanne Ahmari, Assistant Professor, Department of Psychiatry - University of Pittsburgh
    Amit Etkin
    Amit Etkin, Founder and Chief Executive Officer - Alto Neuroscience
    Craig Thompson
    Craig Thompson, CEO - Cerevance
  13. Strategies for Antimicrobial Access in LMICs
    Breakout Session
    • Infectious Disease and Vaccines
    29C
    Jomana Musmar
    Jomana Musmar, Executive Director of the Presidential Advisory Council for Combating Antibiotic - Resistant Bacteria (PACCARB)
    Monika Schneider
    Monika Schneider, Director, Global AMR Policy - Shionogi
    Kevin Outterson
    Kevin Outterson, Executive Director - CARB-X
    Yann Ferrisse
    Yann Ferrisse, Business Development & Partner Engagement Director - GARDP Foundation
  14. The State of Emerging Biotechs: Investment, Deal, and Pipeline Trends
    Special Program
    • Business Development and Finance
    32AB
    Chad Wessel
    Chad Wessel, Director, Industry Analysis - Biotechnology Innovation Organization (BIO)
  15. Ventrix
    Company Presentation
    • Regenerative Medicine
    Company Presentation Theater 3
    Adam Kinsey
    Adam Kinsey, CEO - Ventrix
2:00 PM – 2:15 PM
(PST)
  1. Cha Therapeutics, Inc
    Start-Up Stadium Session
    • Oncology
    5B
    Eric Paulson
    Eric Paulson
  2. Coastar Therapeutics Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Eddie Chung
    Eddie Chung, CEO - Coastar Therapeutics Inc.
  3. Eli Lilly and Company
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Julie Gilmore
    Julie Gilmore, Vice President - Global Head of Gateway Labs - Eli Lilly and Company
  4. Everfront Biotech
    Start-Up Stadium Session
    • Oncology
    5B
    Jui-Hao Lee
    Jui-Hao Lee, Director of Clinical Affairs Dept. - Everfront Biotech
  5. Health~Holland
    Global Innovation Hub 5A
    Wieteke Wouters
    Wieteke Wouters, Program Director - HollandBIO
  6. KaloCyte, Inc.
    Start-Up Stadium Session
    • Cardiovascular
    5B
    Elaine Haynes
    Elaine Haynes, President and CEO - KaloCyte, Inc.
  7. Lixa Pty Ltd
    Start-Up Stadium Session
    • Infectious Disease and Vaccines
    5B
    Maud Eijkenboom
    Maud Eijkenboom, Managing Director - Lixa
  8. Matrubials Inc.
    Start-Up Stadium Session
    • Infectious Disease and Vaccines
    5B
    Ishita Shah
    Ishita Shah, CEO and Co-founder - Matrubials Inc.
  9. Merlin Biotech, Inc.
    Start-Up Stadium Session
    • Oncology
    5B
    Randall Hyer
    Randall Hyer, CEO - Merlin Biotech, Inc.
  10. Oniria Therapuetics SL
    Start-Up Stadium Session
    • Oncology
    5B
    Héctor Garcia Palmer
    Héctor Garcia Palmer, Chief Scientific Officer - Oniria Therapeutics
  11. PHIOGEN
    Start-Up Stadium Session
    • Infectious Disease and Vaccines
    5B
    Amanda Burkardt
    Amanda Burkardt, CEO - PHIOGEN
  12. Seamless Viral Vector Tech Transfer at Any Phase Offering Stability in Times of Change
    BioProcess Theater Session
    Ramin Baghirzade
    Ramin Baghirzade, Senior Director, Global Head Commercial, Gene Therapy CDMO Services - Charles River Laboratories
  13. Start-Up Stadium Tuesday Afternoon
    Start-Up Stadium 5B
  14. Synergy Therapeutics Inc.
    Start-Up Stadium Session
    • Oncology
    5B
    Michael Atkin
    Michael Atkin, CEO - Synergy Therapeutics Inc.
  15. Tachmed Healthcare, Ltd.
    Start-Up Stadium Session
    • Diagnostics and Personalized Medicine
    5B
    Paul Christie
    Paul Christie
  16. Theradaptive, Inc.
    Company Presentation
    • Regenerative Medicine
    Company Presentation Theater 3
    Luis Alvarez
    Luis Alvarez, President & CEO - Theradaptive, Inc.
  17. Ziphius
    Company Presentation
    • Immunology
    Company Presentation Theater 1
    Chris Cardon
    Chris Cardon, CEO - Ziphius
2:10 PM – 2:20 PM
(PST)
  1. BioProcess Insider Interviews: Charles River Laboratories
    BioProcess Theater Session
    Ramin Baghirzade
    Ramin Baghirzade, Senior Director, Global Head Commercial, Gene Therapy CDMO Services - Charles River Laboratories
2:15 PM – 2:30 PM
(PST)
  1. Accelerated Biosciences Corp.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Yuta Lee
    Yuta Lee, CEO - Accelerated Biosciences Corp.
  2. European Innovation Council
    Global Innovation Hub 5A
    Robert Schröder
    Robert Schröder, Head of Sector External Communication (EISMEA) - European Innovation Council
  3. HysensBio
    Company Presentation
    • Regenerative Medicine
    Company Presentation Theater 3
    Yurim Shin
    Yurim Shin, Medical Director - HysensBio
  4. Servier
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Frédéric Scaerou
    Frédéric Scaerou, Head of Global Business Development - Servier
  5. VRG Therapeutics
    Company Presentation
    • Immunology
    Company Presentation Theater 1
    Zalan Peterfi
    Zalan Peterfi, MD, PhD - VRG Therapeutics
2:20 PM – 2:30 PM
(PST)
  1. Panel Discussion on Improving Expression and Manufacturing of Novel Biologics
    Session
2:30 PM – 2:45 PM
(PST)
  1. AaviGen
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Patrick Most
    Patrick Most, CEO - AaviGen
  2. Department of Health Abu Dhabi
    Global Innovation Hub 5A
    Asma Al mannaei
    Asma Al mannaei, executive director of Research and innovation center - Department of Health - Abudhabi
  3. Lineage Cell Therapeutics
    Company Presentation
    • Regenerative Medicine
    Company Presentation Theater 3
    Brian Culley
    Brian Culley, CEO - Lineage Cell Therapeutics
  4. Macrobiome Therapeutics
    Company Presentation
    • Immunology
    Company Presentation Theater 1
    Alex Loukas
    Alex Loukas, Founding Director - Macrobiome Therapeutics
  5. Novartis
    Company Presentation
    • Other
    Company Presentation Theater 2
    Adam Feire
    Adam Feire, Global Head of Search & Evaluation - Novartis
2:45 PM – 3:00 PM
(PST)
  1. AAVogen
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Buel Rodgers
    Buel Rodgers, CEO - AAVogen
  2. Dubai Science Park
    Global Innovation Hub 5A
  3. GC Cell
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 2
    James Park
    James Park, Chief Executive Officer - GC Cell
  4. GSNO Therapeutics, Inc.
    Company Presentation
    • Immunology
    Company Presentation Theater 1
    Matthews Bradley
    Matthews Bradley, CEO and Founder - GSNO Therapeutics, Inc.
  5. Mediwhale Inc.
    Company Presentation
    • AI and Digital Health
    Company Presentation Theater 3
    Kevin Choi
    Kevin Choi, CEO - Mediwhale
3:00 PM – 4:00 PM
(PST)
  1. Breaking the Cycle: Innovations in Addressing Substance Use Disorder
    Breakout Session
    • Brain Health
    26A
    Tam Nguyen
    Tam Nguyen, Program Officer - National Institute on Drug Abuse (NIDA)
    Courtney Miller
    Courtney Miller, Founder, Myosin Therapeutics; Professor Department of Molecular Medicine, Department of Neuroscience - UF Scripps Biomedical Research
    Joanne Peterson
    Joanne Peterson, Founder and Executive Director - Learn to Cope
    James Hickman
    James Hickman, Professor of NanoScience, Chemistry, Biomolecular Science, Physics and Electrical Engineering, University of Central Florida; Chief Scientist - Hesperos
    Retsina Meyer
    Retsina Meyer, Head of Corporate Strategy - Delix
  2. Building a More Sustainable Biopharma Innovation Ecosystem
    Breakout Session
    • Environmental Sustainability
    29C
    Rachel Kaufman
    Rachel Kaufman, Head of Global Sustainability - Avantor
    Joydeep Ganguly
    Joydeep Ganguly, Senior Vice President of Corporate Operations, and Chief Sustainability Officer - Gilead Sciences
    Mark Steen
    Mark Steen, VP, Sustainability and Climate Initiatives - Corning
    Sharon Vidal
    Sharon Vidal, Global Head of Corporate Social Responsibility and Sustainability - Illumina
  3. Combined Therapeutics
    Company Presentation
    • Immunology
    Company Presentation Theater 1
    Romain Micol
    Romain Micol, President and co-founder CEO - Combined Therapeutics
  4. CorrectSequence Therapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Xiaodun (Susan) Mou
    Xiaodun (Susan) Mou, CEO - CorrectSequence Therapeutics
  5. Diakonos Oncology
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Anthony Baldor
    Anthony Baldor, CFO and Head of Business Development - Diakonos Oncology
  6. Fireside Chat
    Fireside Chat with Joshua Boger, PhD, Founder and Former CEO of Vertex Pharmaceuticals; Executive Chairman, Alkeus Pharmaceuticals; Chair of Board, CervoMed
    Fireside Chat
    • Business Development and Finance
    25ABC
    Amber Tong
    Amber Tong, Senior Editor - Endpoints News
    Joshua Boger
    Joshua Boger, Founder and Former CEO of Vertex Pharmaceuticals - Executive Chairman, Alkeus Pharmaceuticals; Chair of Board, CervoMed
  7. From Incubation to Acquisition: The Growth Journey of an Early-Stage Company
    Breakout Session
    • Business Development and Finance
    30ABC
    johnson and johnson
    Melinda Richter
    Melinda Richter, Global Head - Johnson & Johnson
    Matt Lorenzi
    Matt Lorenzi, Vice President - Johnson & Johnson
    Colin Farlow
    Colin Farlow, Co-Founder and CEO - Serotiny
    Eric Moessinger
    Eric Moessinger, Partner - +ND Capital
    Leo MacDonald
    Leo MacDonald, Vice President - Johnson & Johnson Innovative Medicine
  8. Fully Integrated, Digitally Controlled Nested xRNA manufacturing Platform
    BioProcess Theater Session
    Aaron Cowley
    Aaron Cowley, Chief Scientific Officer - ReciBioPharm
  9. Getting Personal: How the Evolving U.S. Privacy Legal Landscape Impacts Biomedical Research
    Breakout Session
    • AI and Digital Health
    24BC
    Justin Pine
    Justin Pine, Senior Director - Biotechnology Innovation Organization (BIO)
    Kimberly Gold
    Kimberly Gold, Chief Privacy Officer - Genentech
    Carla Cartwright
    Carla Cartwright, Head Global Digital and Regulatory Policy - Johnson & Johnson
    David Schwartz
    David Schwartz, Partner - Arnold & Porter
    Paul Friedrichs
    Paul Friedrichs, Maj. Gen. (ret), Deputy Assistant to the President - Director of the Office of Pandemic Preparedness and Response at the White House
  10. Microgravity: A Strategic Advantage in R&D
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Elizabeth Reynolds
    Elizabeth Reynolds, Managing Director - Starburst Aerospace
    Kate Rubins
    Kate Rubins, Astronaut - NASA
    Paul Reichert
    Paul Reichert, Associate Principal Scientist - Merck
    Rob Garmise
    Rob Garmise, Director of Formulations Development, Exploratory Biopharmaceutics - Bristol Myers Squibb
  11. Optimizing the Investability of Your Lead Program: Data-Driven Approaches for Pipeline Prioritization
    Breakout Session
    • Business Development and Finance
    32AB
    Drew Cutshaw
    Drew Cutshaw, Senior Associate, Medical Officer - Pappas Capital
    Mike Grey
    Mike Grey, Chairman - Plexium
    Susan Lenderts
    Susan Lenderts, Head of Life Sciences - SAS Institute, INC
    Ben Davis
    Ben Davis, Vice President, Corporate Alliances - IQVIA
    Lauren Crawford Shaver
    Lauren Crawford Shaver, Head of Healthcare and Life Sciences for the Americas, Senior Managing Director - FTI Consulting
  12. Preparing for Platforms: Sponsor and Regulator Perspectives on the Platform Technology Designation (PTD)
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Dylan Bechtle
    Dylan Bechtle, US Regulatory Policy Lead - Johnson & Johnson
    Snehal Naik
    Snehal Naik, Head of Regulatory Policy - Spark Therapeutics
    Rob Berlin
    Rob Berlin, Head US Regulatory Policy - GSK
    Anne-Virginie Eggimann
    Anne-Virginie Eggimann, Chief Regulatory Officer - Tessera Therapuetics
    Antonella Lozito
    Antonella Lozito, Executive Director, Regulatory Strategy, Infectious Diseases - Moderna
    Nicole Verdun
    Nicole Verdun, Super Office Director, CBER - FDA
  13. Resilience
    Company Presentation
    • Contract Manufacturing Organization
    Company Presentation Theater 3
    Milan Tomic
    Milan Tomic, Senior Director, Process Development - Resilience
  14. Super Session
    Superconvergence: How the AI, Genetics, and Biotechnology Revolutions Will Transform our Lives, Work, and World, new book from Jamie Metzl
    Super Session
    • Next Generation Biotherapeutics
    28ABCDE
    Jamie Metzl
    Jamie Metzl, Founder and Chair - OneShared.World
  15. The Bad and the Ugly: Unpacking Repercussions of the Medicaid Drug Rebate Program Rule
    Breakout Session
    • Value‚ Patient Access and Reimbursement
    29AB
    Patrick Plues
    Patrick Plues, Vice President SGA, Government Affairs and External Relations - Biotechnology Innovation Organization
    Melanie Lendnal
    Melanie Lendnal, Senior Vice President of Policy & Advocacy - ALS Association
    Matt Salo
    Matt Salo, CEO - Salo Health Strategies
    Alice Valder Curran
    Alice Valder Curran, Partner - Hogan Lovells
  16. Workforce, Diversity, Equity, and Inclusion at BIO: Presenting New Survey Data and Exploring Partnerships
    Breakout Session
    • Diversity‚ Equity and Inclusion
    31C
    Ted Love
    Ted Love, Chair - BIO Board of Directors
    Charlotte Jones-Burton
    Charlotte Jones-Burton, Founder - Women of Color in Pharma
    Mark Royal
    Mark Royal, Senior Client Partner - Korn Ferry
    Jane Barry-Moran
    Jane Barry-Moran, Managing Director, Programs & Research - Out Leadership
    Mike Edmondson
    Mike Edmondson, U.S. Vice President, Performance Optimization - Amgen
3:15 PM – 3:30 PM
(PST)
  1. Ananda Immunotherapies
    Company Presentation
    • Immunology
    Company Presentation Theater 3
    Adrian Lim
    Adrian Lim, CEO - Ananda Immunotherapies
  2. Apollomics
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Sanjeev Redkar
    Sanjeev Redkar, President and Co-founder - Apollomics
  3. Japan Bioindustry Association
    Global Innovation Hub 5A
    Yoshiaki Tsukamoto
    Yoshiaki Tsukamoto, Executive Director - Japan Bioindustry Association
  4. Juncell Therapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Ross Ma
    Ross Ma, Head of Business Development - Juncell Therapeutics
  5. Tiba Biotech LLC
    Company Presentation
    • Immunology
    Company Presentation Theater 1
    Jasdave Chahal
    Jasdave Chahal, Founder and Chief Scientist - Tiba Biotech LLC
3:20 PM – 3:30 PM
(PST)
  1. BioProcess Insider Interviews: Hydrosome Labs
    BioProcess Theater Session
    J. Nicholas Jackowetz
    J. Nicholas Jackowetz, SVP, Principal Scientist - Hydrosome Labs
3:30 PM – 3:45 PM
(PST)
  1. Bioprocess Insider Interviews: Syngene
    Session
  2. Exeliom Biosciences
    Company Presentation
    • Inflammation
    Company Presentation Theater 3
    Benjamin Hadida
    Benjamin Hadida, CEO - Exeliom Biosciences
  3. Greenwich LifeSciences
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Snehal PATEL
    Snehal PATEL, CEO - Greenwich Lifesciences, Inc.
  4. Profluent Bio
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Hilary Eaton
    Hilary Eaton, Chief Business Officer - Profluent Bio
  5. XORTX Therapeutics Inc.
    Company Presentation
    • Other
    Company Presentation Theater 1
    Allen Davidoff
    Allen Davidoff, CEO, President, Director - XORTX Therapeutics Inc.
3:40 PM – 4:10 PM
(PST)
  1. Industry Case Study: Gene Editing Technologies: The Future of Personalized Medicine
    BioProcess Theater Session
    Nathan Lewis
    Nathan Lewis, Professor of Pediatrics and Bioengineering - University of California San Diego
3:45 PM – 4:00 PM
(PST)
  1. Avstera Therapeutics Corp.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Karthik Musunuri
    Karthik Musunuri, CEO & Co-Founder - Avstera Therapeutics Corp.
  2. Forge Biologics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Taleen Barsoumian
    Taleen Barsoumian, Vice President - Forge Biologics
  3. Olatec Therapeutics
    Company Presentation
    • Inflammation
    Company Presentation Theater 3
    Mustafa Noor
    Mustafa Noor, Chief Medical Officer - Olatec Theapeutics
  4. Reglagene
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Richard Austin
    Richard Austin, CEO - Reglagene
4:00 PM – 5:00 PM
(PST)
  1. Azome Therapeutics Inc
    Company Presentation
    • Inflammation
    Company Presentation Theater 3
    Elliott Gruskin
    Elliott Gruskin, CEO - Azome Therapeutics, Inc
  2. Bionoxx Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Euna Cho
    Euna Cho, Director - Bionoxx Inc.
  3. GelMEDIX, Inc.
    Company Presentation
    • Ophthalmology
    Company Presentation Theater 4
    Max Cotler
    Max Cotler, COO - GelMEDIX, Inc
  4. Jamie Metzl Book Signing
    Special Program Sails Pavilion
  5. OBI Pharma, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Teng-Yi Huang
    Teng-Yi Huang, Director, R&D Medicinal Chemistry - OBI Pharma, Inc.
4:15 PM – 5:15 PM
(PST)
  1. Adaptive Reuse: Biomanufacturing Enters A New Age
    Breakout Session
    • Environmental Sustainability
    29C
    Matt Gardner
    Matt Gardner, Board Chairman - California Biomanufacturing Center
    TJ Silvey
    TJ Silvey, Director - Raymond James
    Ella Woger-Nieves
    Ella Woger-Nieves, CEO - Invest Puerto Rico
    Gordon Zagar
    Gordon Zagar, President & Founder - ZCI
    Ann-Stewart Patterson
    Ann-Stewart Patterson, Executive Vice President - CBRE
  2. AI-Generated Invention and the Future of Bio R&D
    Breakout Session
    • Intellectual Property
    26B
    Hans Sauer
    Hans Sauer, Deputy General Counsel, VP for IP - Biotechnology Innovation Organization (BIO)
    Ryan Abbott
    Ryan Abbott, Partner - Brown, Neri, Smith & Khan, LLP
    Andrei Iancu
    Andrei Iancu, Partner - Sullivan & Cromwell LLP
    Sarah Korman
    Sarah Korman, General Counsel - Isomorphic Labs
  3. Becoming an Early Innovation Partner of Choice
    Breakout Session
    • Business Development and Finance
    29AB
    David Kane
    David Kane, Managing Partner - Arc Bio Communications
    Helena Chaye
    Helena Chaye, CEO - KaliVir
    Peter Sandor
    Peter Sandor, Head of Corporate Strategy - Astellas Pharma Inc
    Olga Granaturova
    Olga Granaturova, Co-Founder/President - PriveBio
    Anna Chen
    Anna Chen, Principal - Frazier Life Sciences
  4. Best Practices for Managing Your Biotech’s Ca$hflow
    Breakout Session
    • Business Development and Finance
    32AB
    Joel Papernik
    Joel Papernik, Member - Mintz
    Barbara Wood
    Barbara Wood
    Heidi Henson
    Heidi Henson, Director - Lisata Therapeutics
    Robert Easton
    Robert Easton - Eastern Strategy, LLC
  5. Challenging Biotech’s One-Track Mind When it Comes to Neuropsychiatric Drug Innovation
    Breakout Session
    • Brain Health
    26A
    Heather McKenzie
    Heather McKenzie, Senior Editor - BioSpace
    Laxminarayan Bhat
    Laxminarayan Bhat, CEO - Reviva Pharmaceuticals Inc
    Amit Etkin
    Amit Etkin, Founder and Chief Executive Officer - Alto Neuroscience
    Daniel Karlin
    Daniel Karlin, Chief Medical Officer - Mind Medicine (MindMed)
    David Benshoof Klein
    David Benshoof Klein, Co-Founder and CEO - Click Therapeutics
  6. Enveda Biosciences
    Company Presentation
    • Inflammation
    Company Presentation Theater 3
    Bigyan Bista
    Bigyan Bista, Senior Vice President, Head of Business Strategy and Development - Enveda Biosciences
  7. Exploring the Future of Gene Delivery: A Conversation on the Direction for Next-Generation Vectors
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    31AB
    Ola Tuvesson
    Ola Tuvesson, Chief Technology Officer - NorthX Biologics
    Johan Rockberg
    Johan Rockberg, Professor at the Royal Institute of Technology and Director of GeneNova - Royal Institute of Technology
    Amy Walker
    Amy Walker, Vice President of Research and Business Development - 4BaseBio PLC
    Henk Streefkerk
    Henk Streefkerk, CEO & Medical Director - Amarna Therapeutics
    Jayesh Kulkarni
    Jayesh Kulkarni, co-founder and CSO
  8. Exploring the Uncharted: Rare Diseases, Unintended Consequences of the Inflation Reduction Act, and Demonstrating the Value of These Therapies
    Breakout Session
    • Orphan and Rare Disease
    30DE
    alexion logo
    Michele Oshman
    Michele Oshman, Senior Vice President and Head of Patient Advocacy - Biotechnology Innovation Organization (BIO)
    Jason Spangler
    Jason Spangler, Chief Executive Officer - Innovation and Value Initiative’s (IVI)
    Karin Hoelzer
    Karin Hoelzer, Senior Director, Policy and Regulatory Affairs - National Organization for Rare Disorders (NORD)
    Dionne Stalling
    Dionne Stalling, Executive Director - Rare And Black
    Kate Jones
    Kate Jones, Head of Federal Affairs - Alexion, AstraZeneca Rare Disease
  9. Fireside Chat
    Fireside Chat with Dr. Vivian Ota Wang, PhD, Deputy Director, NIH Office of Research on Women's Health
    Fireside Chat
    • Diversity‚ Equity and Inclusion
    25ABC
    Sheila Mikhail
    Sheila Mikhail, Board Member, Women's Health Access Matters; Executive Director - BC Ruckus
    Vivian Ota Wang
    Vivian Ota Wang, Deputy Director - NIH Office of Research on Women's Health
  10. Super Session
    Fireside Chat with John McDonald, Corporate Vice President, Global Head of Business Development and M&A, Novo Nordisk
    Super Session
    • Business Development and Finance
    28ABCDE
    novo nordisk
    Mandy Jackson
    Mandy Jackson, Managing Editor (US Commercial News) - Scrip
    John McDonald
    John McDonald, Corporate Vice President - Novo Nordisk
  11. Future of Biopharma Innovation: Unleashing the Potential of Emerging Therapeutic Modalities in Oncology and Beyond
    Breakout Session
    • Next Generation Biotherapeutics
    23BC
    Romain Bonnot
    Romain Bonnot, Principal - ZS Associates
    Jesper Haaning
    Jesper Haaning, Head of Development External Innovation - Novo Nordisk
    Lucas Donigian
    Lucas Donigian, Executive Director, Business Development - Zymeworks Inc.
    Malik Kaman
    Malik Kaman, Principal - ZS Associates
    Falk Ehmann
    Falk Ehmann, Head of Innovation and Development Accelerator (IDeA) - European Medicines Agency (EMA)
  12. Highlighting the Power of Patient Organizations: Exploring Initiatives That Drive Equitable Impact for Patients and Communities
    Breakout Session
    • Diversity‚ Equity and Inclusion
    31C
    Deepa Dahal
    Deepa Dahal, Co-founder and Partner - DKI Health
    Mary Stutts
    Mary Stutts, Chief Executive Officer - Healthcare Businesswomen's Association
    Joseph Nadglowski
    Joseph Nadglowski, President and Chief Executive Officer - Obesity Action Coalition
    Christine Verini
    Christine Verini, CEO - CancerCare
    Sonali Chopra
    Sonali Chopra, Executive Director, Patient Advocacy Relations - Genentech a Member of the Roche Group
  13. Indee Labs
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 4
    Ryan Pawell
    Ryan Pawell, CEO - Indee Labs
  14. Lynk Pharmaceuticals
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 1
    Michael Vazquez
    Michael Vazquez, Co-Founder & Executive VP (Head of Chemistry) - Lynk Pharmaceuticals
  15. Orca Bio
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Dan Kirby
    Dan Kirby, Chief Commercial Officer - Orca Bio
  16. The Future of Immunology: Path to Precision Medicine
    Breakout Session
    • Diagnostics and Personalized Medicine
    24BC

    merck logo

    Max Bayer
    Max Bayer, Reporter - Endpoints News
    Aileen Lorenzo Pangan
    Aileen Lorenzo Pangan, Vice President & Therapeutic Area Head - Merck
    Cynthia Bens
    Cynthia Bens, Senior Vice President - Personalized Medicine Coalition
    Stephan Targan
    Stephan Targan, Executive Director, F. Widjaja Inflammatory Bowel Disease Institute - Cedars-Sinai
    Andres Hurtado-Lorenzo
    Andres Hurtado-Lorenzo, Senior Vice President - Crohn's and Colitis Foundation
4:30 PM – 4:45 PM
(PST)
  1. AIVITA Biomedical, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Hans Keirstead
    Hans Keirstead, Chairman & CEO - AiVita Biomedical, Inc.
  2. Bionaut
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Michael Shipgelmacher
    Michael Shipgelmacher, CEO & Founder - Bionaut
  3. GlueTacs Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Rob Sons
    Rob Sons, Head of Business Development, North America - GlueTacs Therapeutics
  4. Kannalife Sciences, Inc.
    Company Presentation
    • Inflammation
    Company Presentation Theater 3
    Dean Petkanas
    Dean Petkanas, Chief Executive Officer - Kannalife Sciences, Inc.
4:45 PM – 5:00 PM
(PST)
  1. BrainStorm Therapeutics, Inc.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Robert Fremeau
    Robert Fremeau, Founder and CSO - BrainStorm Therapeutics, Inc.
  2. Calviri
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Stephen Johnston
    Stephen Johnston, CEO - Calviri, Inc.
  3. RADIOPHARM THERANOSTICS
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Riccardo Canevari
    Riccardo Canevari, CEO - Radiopharm Theranostics
  4. Serpass Biologics, Inc.
    Company Presentation
    • Inflammation
    Company Presentation Theater 3
    Alexandra Lucas
    Alexandra Lucas, Professor - Serpass Biologics inc.
5:00 PM – 6:30 PM
(PST)
  1. Exhibition Reception
    Reception
9:00 AM – 10:30 AM
(PST)
  1. Keynote: Admiral William H. McRaven, U.S. Navy Four-Star Admiral (Retired)
    Main Stage Program Ballroom 20
    John Crowley
    John Crowley, President & CEO - Biotechnology Innovation Organization (BIO)
    William McRaven
    William McRaven, U.S. Navy Four-Star Admiral (Retired)
  2. Main Stage Opening Program
    Main Stage Program Ballroom 20
    John Crowley
    John Crowley, President & CEO - Biotechnology Innovation Organization (BIO)
    Jason Kelly
    Jason Kelly, Chair, National Security Commission on Emerging Biotechnology - Co-Founder and CEO, Gingko Bioworks
10:30 AM – 10:45 AM
(PST)
  1. BioMap
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Per Greisen
    Per Greisen, President - BioMap
  2. Gritgen Therapeutics Co., Ltd.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 2
    Fenglan Wu
    Fenglan Wu, Co-founder and CEO - Gritgen Therapeutics
  3. Incorporating New Technologies in Development and Production, Regulatory Landscapes, and Agile Manufacturing
    BioProcess Theater BioProcess Theater
  4. T-knife Therapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 3
    Elisa Kieback
    Elisa Kieback, Chief Technology Officer - T-knife Therapeutics
  5. TransCode Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Zdravka Medarova
    Zdravka Medarova, Chief Scientific Officer - TransCode Therapeutics
  6. Welcome To Day Two
    BioProcess Theater Session
    Dan Stanton
    Dan Stanton, Founder and Managing Editor - BioProcess Insider
10:45 AM – 11:15 AM
(PST)
  1. miRecule Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Anthony Saleh
    Anthony Saleh, CEO/Founder - miRecule Inc.
  2. Oxford Biotherapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Mattthew Metzger
    Mattthew Metzger, Program, Alliance and Business Development Manager - Oxford Biotherapeutics
  3. Sinopia Biosciences, Inc.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Iman Famili
    Iman Famili, President & CEO - Sinopia Biosciences, Inc.
  4. Strategies for Integrated Development and Manufacturing: Adapting Batch Platforms and Facilities for Multimodal Biopharmaceutical Production and Continuous Processing
    BioProcess Theater Session
    David Jen
    David Jen, Principal Consultant - Bioblue CMC Manufacturing Consulting LLC
    Mohammed Albadrani
    Mohammed Albadrani, San Diego Office Lead - Wunderlich-Malec Engineering
  5. ThromBio Holdings
    Company Presentation
    • Cardiovascular
    Company Presentation Theater 3
    Peter Bush
    Peter Bush, Chief Executive Officer - ThromBio
11:00 AM – 1:00 PM
(PST)
  1. Achieving Commercial Success Through the National Institutes of Health's Intramural Research Program
    Breakout Session
    • Business Development and Finance
    32AB
    Michael Salgaller
    Michael Salgaller, Supervisory Specialist, National Cancer Institute Tech Transfer Center - National Institutes of Health (NIH)
    Mark Rohrbaugh
    Mark Rohrbaugh, Special Advisor for NIH Technology Transfer - National Institutes of Health (NIH)
    Jeffery Alexander
    Jeffery Alexander, Director, Innovation Policy - RTI International
    Richard Colvin
    Richard Colvin, Chief Medical Officer - bluebird bio
    Maggie Scully
    Maggie Scully, Director, Partnership Development Office - Frederick National Laboratory for Cancer Research
  2. Aluda Pharmaceuticals
    Start-Up Stadium Session
    • Immunology
    5B
    Deebie Symmes
    Deebie Symmes, CBO/COO - Aluda Pharmaceuticals
  3. Ananda Devices
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Margaret Magdesian
    Margaret Magdesian, CEO and Founder - Ananda Devices
  4. Biotech Partnering in Stormy Seas: Key Insights on Charting a Course to Successful Deal-Making through a Choppy Market
    Breakout Session
    • Business Development and Finance
    29AB
    Kate Hillier
    Kate Hillier, Partner - Cooley LLP
    Barbara Kosacz
    Barbara Kosacz, COO and General Counsel - Kronos Bio
    Joseph Baroldi
    Joseph Baroldi, Executive Vice President, Chief Business Officer Ionis Pharmaceuticals - Ionis Pharmaceuticals
    Stacy Feld
    Stacy Feld, Regional Head - Johnson & Johnson
  5. Breaking the Rare Disease Deadlock through Multi-Stakeholder Collaboration
    Breakout Session
    • Orphan and Rare Disease
    26A
    Niklas Blomberg
    Niklas Blomberg, Executive Director - Innovative Health Initiative
    Annette Bakker
    Annette Bakker, President - Children's Tumor Foundation
    Klaus Romero
    Klaus Romero, Chief Executive Officer, Chief Science Officer - Critical Path Institute
    Deborah Requesens
    Deborah Requesens, Director, JumpStart Program - Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania
    Claire Skentelbery
    Claire Skentelbery, Director General - EuropaBio
  6. Coastar Therapeutics Inc.
    Start-Up Stadium Session
    • Cell and Gene Therapy and Genome Editing
    5B
    Eddie Chung
    Eddie Chung, CEO - Coastar Therapeutics Inc.
  7. Cytimm Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Haining Huang
    Haining Huang, President - Cytimm Therapeutics
  8. CytoArm Co.,Ltd.
    Start-Up Stadium Session
    • Oncology
    5B
    Kuo-Hsiang Chuang
    Kuo-Hsiang Chuang, Chief Executive Officer - CytoArm Co.,Ltd.
  9. Dyadic International Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Mark Emalfarb
    Mark Emalfarb, Chief Executive Officer - Dyadic International, Inc.
  10. Fzata, Inc.
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Elizabeth Smith
    Elizabeth Smith, Chief Business Officer - Fzata, Inc.
  11. How to De-Risk Drug Development from the Earliest Stages
    Breakout Session
    • Business Development and Finance
    23BC
    parexel biotech
    Seema Kumar
    Seema Kumar, CEO - Cure at 345 Park Avenue
    Wyatt Gotbetter
    Wyatt Gotbetter, Senior Vice President and Worldwide Head, Access Consulting - PAREXEL
    Abhiram Rao
    Abhiram Rao, Director - EQT Life Sciences
    Ned Wydysh
    Ned Wydysh, Vice President - Health Advances, LLC
    Dan Gold
    Dan Gold, Retired President and CEO - MEI Pharma
    Susan Billings
    Susan Billings, Chief Commercial Officer - Vivodyne
  12. ImmunoShield Therapeutics
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Matthew Becker
    Matthew Becker
  13. Isosterix, Inc.
    Start-Up Stadium Session
    • Oncology
    5B
    Roopa Rai
    Roopa Rai, Founder and CEO - Isosterix, Inc.
  14. Minutia
    Start-Up Stadium Session
    • Cell and Gene Therapy and Genome Editing
    5B
    Katy Digovich
    Katy Digovich, CEO - Minutia
  15. NemaGen Discoveries
    Start-Up Stadium Session
    • Immunology
    5B
    Nicholas Shubin
    Nicholas Shubin, CEO - NemaGen Discoveries
  16. Neuronascent, Inc.
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Judith Kelleher-Andersson
    Judith Kelleher-Andersson, Founder and CEO - Neuronascent
  17. Open Innovation in Life Sciences, Decades of Experiences, Time to Regroup!
    Breakout Session
    • Translational Research
    31AB
    Lucie Rochard
    Lucie Rochard, External Engagement Lead, R&D - Sanofi
    Karen Chandross
    Karen Chandross, Head, Strategic Initiatives and Scientific Relations N.A. • R&D North America - Sanofi
    Florian Montel
    Florian Montel, Head of Open Sciences - Boehringher Ingelheim
    Pamela Hill
    Pamela Hill, Sr. Director, Head of Open Innovation Program - Astra Zeneca
    Vinit Nijhawan
    Vinit Nijhawan, Managing Director - Mass Ventures
  18. Perspectives from Women Powerbrokers
    Breakout Session
    • Diversity‚ Equity and Inclusion
    31C
    Joshua Fox
    Joshua Fox, Member - Mintz
    Anna Turetsky
    Anna Turetsky, Principal, Venture Investments - The Mark Foundation for Cancer Research
    Laura Indolfi
    Laura Indolfi, Chief Executive Officer and Co-Founder - PanTher Therapeutics
    Sabrina Johnson
    Sabrina Johnson, President and CEO - Daré Bioscience, Inc.
    Sheila Gujrathi
    Sheila Gujrathi, Chairwoman and Director - ADARx, Ventyx, ImmPACT, Janux
  19. Post-Guidance Opportunities and Challenges with Prescription Drug Use-Related Software (PDURS)
    Breakout Session
    • AI and Digital Health
    24BC
    Rob Berlin
    Rob Berlin, Head US Regulatory Policy - GSK
    Eva Temkin
    Eva Temkin, Partner - Arnold & Porter
    Renee Beaver
    Renee Beaver, Director, Corporate Counsel - Otsuka America Pharmaceutical, Inc
  20. Psilera
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Chris Witowski
    Chris Witowski, Co-Founder and CEO - Psilera
  21. Rising to the Challenge of Science Regulation: Ensuring Public Policy Keeps Pace with Innovation Ecosystem
    Breakout Session
    • Widening the Bioeconomy
    29C
    Tad Sonstegard
    Tad Sonstegard, Chief Executive & Scientific Officer - Acceligen
    Cameron Bishop
    Cameron Bishop, Head of Washington Office - J.R. Simplot Company
    Emily Carlton
    Emily Carlton, SAF Policy Specialist - LanzaJet
  22. Start-Up Stadium Wednesday Morning
    Start-Up Stadium 5B
  23. Using AI/ML for Identification and Optimization of Therapeutic Molecules
    Breakout Session
    • AI and Digital Health
    30ABC
    johnson and johnson
    Michal Preminger
    Michal Preminger, Regional Head - Johnson & Johnson Innovation East North America
    Justin Scheer
    Justin Scheer, Vice President, Global Head, In Silico Discovery - Johnson & Johnson Innovative Medicine
    Joe McDonald
    Joe McDonald, Chief Data Officer - Odyssey Therapeutics
    Mark DePristo
    Mark DePristo, CEO and Co-Founder - BigHat Biosciences
    Eeshit Dhaval Vaishnav
    Eeshit Dhaval Vaishnav, Founder and CEO - Sequome
    Jim Edwards
    Jim Edwards, Venture Partner - Samsara BioCapital Partner
11:15 AM – 11:30 AM
(PST)
  1. ADP
    Company Presentation
    • Other
    Company Presentation Theater 3
    Kevin Morrissey
    Kevin Morrissey, Sales Executive - ADP
  2. Bexion Pharmaceuticals
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Scott Shively
    Scott Shively, CEO - Bexion Pharmaceuticals
  3. Novoron Bioscience
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Travis Stiles
    Travis Stiles, CEO & CSO - Novoron Bioscience, Inc.
  4. PassPort Technologies, Inc.
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Jeremiah Meloch
    Jeremiah Meloch, Business Development Representative - PassPort Technologies Inc.
11:20 AM – 11:40 AM
(PST)
  1. Opportunities and challenges in developing a fully connected continuous manufacturing process for biologics
    BioProcess Theater Session
    Himanshu Gadgil
    Himanshu Gadgil, CEO - Enzene Inc., USA
11:30 AM – 1:00 PM
(PST)
  1. Alphyn Biologics, Inc.
    Company Presentation
    • Dermatology
    Company Presentation Theater 3
    Neal Koller
    Neal Koller, Chairman & CEO - Alphyn Biologics
  2. Immuto Scientific
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Faraz Choudhury
    Faraz Choudhury, CEO - Immuto Scientific
  3. MAIA Biotechnology, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Vlad Vitoc
    Vlad Vitoc, Founder, Chairman and CEO - MAIA Biotechnology
  4. Praetego Inc
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Pepper Landson
    Pepper Landson, CEO - Praetego Inc
  5. Premier & General Attendee Lunch
    Session Sails Pavilion
11:40 AM – 12:00 PM
(PST)
  1. Introducing the next cycle of affinity resin innovation
    BioProcess Theater Session
    David Cartmell
    David Cartmell, Principle Applications Scientist, Purolite, an Ecolab Company David Cartmell, Product Manager - Purolite, an Ecolab Company
11:45 AM – 12:00 PM
(PST)
  1. Accuronix Therapeutics, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Bradley Keller
    Bradley Keller, President & CEO - Accuronix Therapeutic Inc.
  2. Caliway Biopharmaceuticals Co.,Ltd.
    Company Presentation
    • Dermatology
    Company Presentation Theater 2
    April Yuan
    April Yuan, VP, Business Development & Public Affairs - Caliway
  3. Kayothera
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Mark Esposito
    Mark Esposito, Founder & VP - Kayothera Inc
  4. Medicus Pharma LTD.
    Company Presentation
    • Dermatology
    Company Presentation Theater 3
    Erica Monaco
    Erica Monaco, Chief Operating Officer - Medicus Pharma
12:00 PM – 12:15 PM
(PST)
  1. Avelos Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Young-Whan Park
    Young-Whan Park, CEO - Avelos Therapeutics
  2. Azitra Inc.
    Company Presentation
    • Dermatology
    Company Presentation Theater 3
    Travis Whitfill
    Travis Whitfill, Chief Operating Officer - Azitra Inc.
  3. BioProcess Insider Interviews: KBI
    BioProcess Theater Session
    J. D. Mowery
    J. D. Mowery, President and CEO - KBI Biopharma
  4. Company Presentations Wednesday
    Company Presentation Session Company Presentation Theaters
    johnson and johnson
  5. Nxera Pharma
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Chris Cargill
    Chris Cargill, Chief Executive Officer - Nxera Pharma
  6. Qprotyn Inc
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Janak Vadgama
    Janak Vadgama, Head of BD and Customer Experience - Qprotyn Inc
12:10 PM – 12:20 PM
(PST)
  1. BioProcess Insider Interviews: Rentschler
    BioProcess Theater Session
    Benedikt von Braunmühl
    Benedikt von Braunmühl, CEO - Rentschler Biopharma
12:15 PM – 12:30 PM
(PST)
  1. Deep Genomics
    Company Presentation
    • Platform for Therapeutics
    Company Presentation Theater 4
    Brendan Frey
    Brendan Frey, Founder, Chief Innovation Officer - Deep Genomics
  2. DermaXon LLC
    Company Presentation
    • Dermatology
    Company Presentation Theater 3
    Philippe Diaz
    Philippe Diaz, CEO - Dermaxon Llc
  3. Super Session
    From Chasing My Cure to Every Cure: Dr. David Fajgenbaum on the Power of AI to Repurpose Medicines [LUNCH IN ROOM]
    Super Session
    • Patient Advocacy
    28ABCDE
    Michele Oshman
    Michele Oshman, Senior Vice President and Head of Patient Advocacy - Biotechnology Innovation Organization (BIO)
    David Fajgenbaum
    David Fajgenbaum, Associate Professor of Medicine (Translational Medicine and Human Genetics), Perelman School of Medicine, University of Pennsylvania; - Co-Founder & President, Every Cure
  4. Rakuten Medical, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Abhijit Bhatia
    Abhijit Bhatia, Chief Operating Officer - Rakuten Medical, Inc.
  5. Sanofi
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Ulrich Wendt
    Ulrich Wendt, Global Head of Business Development, Immunology & Inflammation - Sanofi
12:20 PM – 1:00 PM
(PST)
  1. State of the Industry BioProcess Insider Round Table
    BioProcess Theater Session
    Himanshu Gadgil
    Himanshu Gadgil, CEO - Enzene Inc., USA
    Ninette van Lingen
    Ninette van Lingen, Senior Vice President Business Development - Just-Evotec Biologics
    Brad Stewart
    Brad Stewart, , Market Managing Principal, National Life Sciences Leader - BDO
1:00 PM – 1:30 PM
(PST)
  1. Industry Case Study: Latest Analytical Technologies and Approaches for Bioprocessing
    BioProcess Theater Session
    Kevin Zen
    Kevin Zen, Senior Director - IGM Biosciences
1:30 PM – 2:45 PM
(PST)
  1. Driving Therapies Forward with the End Goal in Mind
    BioProcess Theater Session
    Jesse McCool
    Jesse McCool, co-founder and CEO - Wheeler Bio
    Nicholas Ostrout
    Nicholas Ostrout, Senior Director Strategic Accounts & Partnerships - Charles River Laboratories
    Ian Wyllie
    Ian Wyllie, Director, Operations, RightSource - Charles River Laboratories
    Samuel Chuang
    Samuel Chuang, Senior Principal Scientific Advisor - Charles River Laboratories
  2. Student Program: Entry into Early Careers in Biotechnology
    Special Program
    • Diversity‚ Equity and Inclusion
    29AB
    Stanley Maloy
    Stanley Maloy, Emeritus Associate VP for Innovation and Professor of Microbiology - San Diego State University
    Justin Scheer
    Justin Scheer, Vice President, Global Head, In Silico Discovery - Johnson & Johnson Innovative Medicine
    Ann Lee-Karlon
    Ann Lee-Karlon, Chief Executive Officer and President - EpiBiologics
    Steven Bloom
    Steven Bloom, Chief Business Officer - Vincerx Pharma
    Sonali Chopra
    Sonali Chopra, Executive Director, Patient Advocacy Relations - Genentech a Member of the Roche Group
1:45 PM – 2:45 PM
(PST)
  1. Advancing Innovation: Best Practices for University-Industry Collaboration
    Breakout Session
    • Translational Research
    31AB
    Ed Pagani
    Ed Pagani, Executive Director, Office for External Partnerships, and Assistant VP, External Partnerships - Duke University
    Caroline Lowenthal
    Caroline Lowenthal, Alliance Manager - MIT
    Tari Suprapto
    Tari Suprapto, Director, Search & Evaluation (Western US & Canada) - Novo Nordisk
    Sunita Rajdev
    Sunita Rajdev, Director - Licensing and Strategic Alliances, Life Sciences - Stanford University
    Doug Krafte
    Doug Krafte, Site Head – Durham, North Carolina, and Sr. Vice President, Ion Channels/Transporters - OmniAb
  2. Applied AI & Advanced Automation in Clinical Development
    Breakout Session
    • AI and Digital Health
    30ABC
    propharma
    Bryan Katz
    Bryan Katz, Chief Strategy Officer - ProPharma
    Kirk Wroblewski
    Kirk Wroblewski, Chief Information Officer - ProPharma
  3. Biotech Innovations for Pet Health
    Breakout Session
    • Widening the Bioeconomy
    29C
    Ellen Carlin
    Ellen Carlin, Vice President - Pathway Policy Group
    Tammie Wahaus
    Tammie Wahaus, CEO - Elias Animal Health LLC
    Dylan Balsz
    Dylan Balsz, CEO - Anivive Lifesciences
    Hervé Poulet
    Hervé Poulet, Director of Strategic Partnering for Animal Health - Boehringer Ingelheim
  4. Building Winning Presentations and Using Emotional Intelligence as a Tool for Success
    Breakout Session
    • Business Development and Finance
    32AB
    Elise Simard
    Elise Simard, Speaker Trainer/Coach - LaVoieHealthScience
    Donna LaVoie
    Donna LaVoie, Founder & CEO - LaVoieHealthScience
  5. Cell Therapy Primer
    Breakout Session
    • Cell and Gene Therapy and Genome Editing
    23BC
    Kevin Curran
    Kevin Curran, Scientific Advisor and Instructor - BioTech Primer
  6. Diversifying the Talent Pipeline: Industry-Recognized Curriculum for a Skilled Workforce
    Breakout Session
    • Diversity‚ Equity and Inclusion
    31C
    Vicki Brannock
    Vicki Brannock, Senior Director Workforce Strategy & Innovation - Biocom California Institute
    Scott Eaker
    Scott Eaker, Chief Operations Officer - Prolacta
    Willie Zuniga
    Willie Zuniga, Retired, Former President and Site Head - Grifols Biologicals
    Judith Velasco
    Judith Velasco, Executive Director - Verdugo Workforce Development Board
    Linnea Fletcher
    Linnea Fletcher, Executive Director - InnovATEBIO, National Biotechnology Center
  7. Johnson & Johnson
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Stacy Feld
    Stacy Feld, Regional Head - Johnson & Johnson
  8. New Tools, New Times: Chemical and Structural AI for Drug Discovery
    Breakout Session
    • AI and Digital Health
    24BC
    Ayman AlAbdallah
    Ayman AlAbdallah, Partner - Mubadala Capital
    Lee Cronin
    Lee Cronin, Founder and Chief Executive Officer - Chemify
    Raphael Townshend
    Raphael Townshend, Founder & CEO - Atomic AI
    Tom Miller
    Tom Miller, CEO and co-founder - Iambic Therapeutics
  9. Phrontline Biopharma
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Tony (Zhaoyuan) Chen
    Tony (Zhaoyuan) Chen, CEO - Phrontline Biopharma
  10. Pioneering Paths: Navigating the Frontiers of First-in-Class
    Breakout Session
    • Next Generation Biotherapeutics
    30DE
    bayer
    Juergen Eckhardt
    Juergen Eckhardt, EVP and Head of Leaps by Bayer - Head of Business Development & Licensing, Pharmaceuticals Division, Bayer
    Seth Ettenberg
    Seth Ettenberg, President and CEO - BlueRock Therapeutics
    John Wu
    John Wu, Managing Director and Partner - Boston Consulting Group
    Hanadie Yousef
    Hanadie Yousef, Chief Executive Officer and Co-Founder - Juvena Therapeutics
    Aleksandra Rizo
    Aleksandra Rizo, CEO - Vividion
  11. PlaqueTec
    Company Presentation
    • Cardiovascular
    Company Presentation Theater 3
    Simon Williams
    Simon Williams, General Manager - PlaqueTec
  12. The Oncology Endgame: Assemble and Shine with AI and Precision Medicine, or Lose.
    Breakout Session
    • Oncology
    26B
    Karim Budhwani
    Karim Budhwani, CEO-Scientist - CerFlux
    Sandeep Menon
    Sandeep Menon, Chief Development Officer, Head of Development and Safety - Alnylam
    Maggie Scully
    Maggie Scully, Director, Partnership Development Office - Frederick National Laboratory for Cancer Research
    Kara Bortone
    Kara Bortone, Senior Director, J&J Innovative Medicine Business Development - Johnson & Johnson
  13. Zymeworks
    Company Presentation
    • Other
    Company Presentation Theater 4
    Emily Chen
    Emily Chen, Associate Director, Business Development - Zymeworks
2:00 PM – 4:00 PM
(PST)
  1. AcroCyte Therapeutics Inc
    Start-Up Stadium Session
    • Tools/Drug Development Support Tech
    5B
    Ying Chih Chang
    Ying Chih Chang, Chief Executive Officer - AcroCyte Therapeutics Inc
  2. AgenT
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Baptiste Billoir
    Baptiste Billoir, Co-founder - AgenT
  3. Bioprocess Insider Interviews: IP Law
    BioProcess Theater Session
  4. GelSana Therapeutics, Inc.
    Start-Up Stadium Session
    • Inflammation
    5B
    Melissa Krebs
    Melissa Krebs, CEO - GelSana Therapeutics, Inc.
  5. GenEndeavor LLC
    Company Presentation
    • Diagnostics and Personalized Medicine
    Company Presentation Theater 4
    Ricardo Mancebo
    Ricardo Mancebo, CEO - GenEndeavor LLC
  6. GenVivo, Inc.
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Robert Johnson
    Robert Johnson, COO - GenVivo
  7. Incircular
    Start-Up Stadium Session
    • Tools/Drug Development Support Tech
    5B
    Saskia Neubacher
    Saskia Neubacher, CEO - Incircular
  8. Keliomics, Inc.
    Start-Up Stadium Session
    • Tools/Drug Development Support Tech
    5B
    Frank Lau
    Frank Lau, CEO - Keliomics, Inc.
  9. LonGieva Therapeutics
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Mehrdad Shamloo
    Mehrdad Shamloo
  10. Mikrobiomik Healthcare Co. S.L.
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Patricia Del Río
    Patricia Del Río, BUSINESS DEVELOPMENT & INNOVATION DIRECTOR - Mikrobiomik Healthcare
  11. Neuroene Therapeutics
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Sherine Chan
    Sherine Chan, CEO and Co-Founder - Neuroene Therapeutics
  12. Novartis Contract Manufacturing
    Company Presentation
    • Other
    Company Presentation Theater 2
    Harald Oberegger
    Harald Oberegger
  13. Orlia
    Start-Up Stadium Session
    • Tools/Drug Development Support Tech
    5B
    Christina McGraw
    Christina McGraw, Associate Professor - University of Otago
  14. Pelagos Pharmaceuticals, Inc.
    Company Presentation
    • Cardiovascular
    Company Presentation Theater 3
    Dan Watkins
    Dan Watkins, CEO - Pelagos Pharmaceuticals, Inc.
  15. SiNON Nano Sciences
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Afreen Allam
    Afreen Allam, Founder & CEO - SiNON Nano Sciences
  16. Start-Up Stadium Wednesday Afternoon
    Start-Up Stadium 5B
  17. VoxCell BioInnovation
    Start-Up Stadium Session
    • Tools/Drug Development Support Tech
    5B
    Kevin Vos
    Kevin Vos
2:10 PM – 2:20 PM
(PST)
  1. Bioprocess Insider Interviews
    BioProcess Theater Session
2:15 PM – 2:30 PM
(PST)
  1. Inocras Inc.
    Company Presentation
    • Diagnostics and Personalized Medicine
    Company Presentation Theater 4
    Jehee Suh
    Jehee Suh, CEO - Inocras Inc.
  2. InvivoSciences, Inc.
    Company Presentation
    • Cardiovascular
    Company Presentation Theater 3
    Ayla Annac
    Ayla Annac, CEO/Co-Founder - InvivoSciences, Inc.
  3. Pfizer Inc.
    Company Presentation Company Presentation Theater 2
  4. Sernova Corp
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Cynthia Pussinen
    Cynthia Pussinen, CEO - Sernova
2:20 PM – 2:30 PM
(PST)
  1. BioProcess Insider Focus Presentation: Continuous Biomanufacturing for Increasing Access to Biologics
    BioProcess Theater Session
    Jon Gunther
    Jon Gunther, Vice President of Business Development - Just-Evotec Biologics
2:30 PM – 2:45 PM
(PST)
  1. AUM Biosciences
    Company Presentation
    • Oncology
    Company Presentation Theater 2
    Vishal Doshi
    Vishal Doshi, CEO - AUM Biosciences
  2. BERTIS
    Company Presentation
    • Diagnostics and Personalized Medicine
    Company Presentation Theater 4
    Donghan Lee
    Donghan Lee, Strategic planning team leader - BERTIS
  3. Challenges faced with conventional fed-batch process; EnzeneX™ : The solution and future of biologics manufacturing
    BioProcess Theater Session
    Himanshu Gadgil
    Himanshu Gadgil, CEO - Enzene Inc., USA
  4. Papillon Therapeutics, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Carter Cliff
    Carter Cliff, CEO - Papillon Therapeutics, Inc.
  5. XyloCor Therapeutics
    Company Presentation
    • Cardiovascular
    Company Presentation Theater 3
    Albert Gianchetti
    Albert Gianchetti, Chief Executive Officer - XyloCor Therapeutics
2:40 PM – 3:00 PM
(PST)
  1. Insider Panel Discussion: Fed Batch Versus Continuous
    BioProcess Theater Session
    Jon Gunther
    Jon Gunther, Vice President of Business Development - Just-Evotec Biologics
    Himanshu Gadgil
    Himanshu Gadgil, CEO - Enzene Inc., USA
2:45 PM – 3:00 PM
(PST)
  1. CeleCor Therapeutics
    Company Presentation
    • Cardiovascular
    Company Presentation Theater 3
    Robert Hillman
    Robert Hillman, CEO - CeleCor Therapeutics
  2. Modality.AI, Inc.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    David Suendermann-Oeft
    David Suendermann-Oeft, CEO - Modality.AI
  3. Panolos Bioscience, Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    David Yang
    David Yang, Research Director - Panolos Bioscience, Inc.
  4. Sarcomatrix Therapeutics Corp.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    David Craig
    David Craig, President and CEO - Sarcomatrix Therapeutics Corp
3:00 PM – 4:00 PM
(PST)
  1. AI's Impact on Oncology Cancer Drug Development
    Breakout Session
    • Oncology
    26B
    Wyatt McDonnell
    Wyatt McDonnell, CEO & Co-founder - Infinimmune
    Jakob Dupont
    Jakob Dupont, Executive Partner - Sofinnova Investments
    Kamni Vijay
    Kamni Vijay, CEO - Enable Medicine
    Andrei Georgescu
    Andrei Georgescu, CEO & Co-founder - Vivodyne
    Daniel Silva Manzano
    Daniel Silva Manzano, CEO & Co-Founder - Monod Bio
    Abe Heifets
    Abe Heifets, CEO & Co-Founder - Atomwise
  2. Blueprints for Biotech: Designing Deals that Deliver
    Breakout Session
    • Business Development and Finance
    32AB
    Matthew Hudes
    Matthew Hudes, Founder & CEO - bdlBiologx
    Christopher Walsh
    Christopher Walsh, Senior Vice President, General Counsel - Denali Therapeutics Inc.
    Bryan Glaser
    Bryan Glaser, Senior Vice President, Business Development - Invenra Inc.
    Saira Ramasastry
    Saira Ramasastry, Partner - Sanacor
    Grace Han McMahon
    Grace Han McMahon, Associate Vice President and Head of Merck’s BD&L Pacific Innovation Hub - Merck
  3. Cytiva
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Katrin Herrmann
    Katrin Herrmann, Senior Director, Global Strategic Accounts - Cytiva
  4. Developing Successful DEI Programs for Life Sciences Companies
    Breakout Session
    • Diversity‚ Equity and Inclusion
    31C
    Marredia Crawford
    Marredia Crawford, Chief Inclusion, Diversity and Equity Officer - Baker McKenzie
    Nicole Stovall
    Nicole Stovall, AVP, Diversity Strategy and Innovation - Merck
    Alessandra Ravetti
    Alessandra Ravetti, Senior Vice President, Associate General Counsel - Regeneron Pharmaceuticals
    Matthew Silversten
    Matthew Silversten, Head of Litigation, Investigations, Employment & Governance - Astellas
  5. Driving Biotech Success: What Every CEO Needs from Her C-Level Team
    Breakout Session
    • Business Development and Finance
    29AB
    Mary Haak-Frendscho
    Mary Haak-Frendscho, President and CEO - Spotlight Therapeutics
    Karen Boezi
    Karen Boezi, Chief Operating Officer - Thirona Biosciences
    Seema Kantak
    Seema Kantak, Senior Vice President, Biotherapeutics - Exelixis
    Cindy Dunkle
    Cindy Dunkle, Chief People Officer - Denali
  6. InVivo Biosystems
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Kat McCormick
    Kat McCormick, CEO - InVivo Biosystems
  7. Navigating the Intersection of National Security and Advances in Emerging Biotechnology
    Breakout Session
    • Widening the Bioeconomy
    29C
    Phyllis Arthur
    Phyllis Arthur, Senior Vice President, Infectious Disease & Emerging Science Policy - Biotechnology Innovation Organization (BIO)
    Alina Meltaus
    Alina Meltaus, Chief of Staff - National Security Commission on Emerging Biotechnology
    Steven Moss
    Steven Moss, Senior Policy Advisor - National Security Commission on Emerging Biotechnology
    Keeley Mui
    Keeley Mui, Senior Policy Advisor - National Security Commission on Emerging Biotechnology
  8. Obesity Therapies: Present and Future Opportunities
    Breakout Session
    • Business Development and Finance
    30ABC
    novo nordisk
    Tomas Landh
    Tomas Landh
    Kasper Veje
    Kasper Veje, Vice President, Head of Diabetes & Obesity Search and Evaluation - Novo Nordisk
    Brian Bloomquist
    Brian Bloomquist, Chief Business and Strategy Officer - Alveus Therapeutics
    Andrew Whittle
    Andrew Whittle, Director, Strategic Partnering, Cardiometabolism & Retinal Health - Boehringer Ingelheim
    Su Zhang
    Su Zhang, VP, Global Head of Business Development - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  9. Organizing to Derisk Academic Assets
    Breakout Session
    • Translational Research
    31AB
    Michelle Hoffmann
    Michelle Hoffmann, Executive Director - Chicago Biomedical Consortium
    Lisa Dhar
    Lisa Dhar, Associate Vice President for Innovation and New Ventures - Northwestern Innovation and New Ventures Office
    Aleks Baranczak
    Aleks Baranczak, Chief Program Officer - Blackbird Labs
    Jonathan Young
    Jonathan Young, Head of WARF Therapeutics - Wisconsin Alumni Research Foundation (WARF)
    Raheleh Hatami
    Raheleh Hatami, Scientific Collaboration Director - Deerfield Management
  10. PDABs and the IRA: The Impact of Federal Legislation on State-Level Prescription Pricing Practices
    Breakout Session
    • Value‚ Patient Access and Reimbursement
    23BC
    Elizabeth (Liz) Helms
    Elizabeth (Liz) Helms, President and CEO - California Chronic Care Coalition
    John O’Brien
    John O’Brien, President and CEO - National Pharmaceutical Council
    Brett Johnson
    Brett Johnson, Director, State Government Affairs - Amgen
    Tiffany Westrich-Robertson
    Tiffany Westrich-Robertson, Chief Executive Officer and Co-Founder - AiArthritis
    Alice Valder Curran
    Alice Valder Curran, Partner - Hogan Lovells
  11. PFDDs and Beyond: Different Roads to Patient-Inspired Drug Development
    Breakout Session
    • Patient Advocacy
    25ABC
    travere
    Sika Dunyoh
    Sika Dunyoh, Senior Director of Patient Advocacy - Travere Therapeutics
    Danaé Bartke
    Danaé Bartke, Person living with HCU, Executive Director - HCU Network America
    Reenie McCarthy
    Reenie McCarthy, CEO - Stealth BioTherapeutics
    Jessica Tome Garcia
    Jessica Tome Garcia, Associate Director, Research Programs - The Michael J. Fox Foundation for Parkinson's Research
    Stacey Frisk
    Stacey Frisk, Executive Director - Rare Disease Company Coalition
  12. scPharmaceuticals
    Company Presentation
    • Cardiovascular
    Company Presentation Theater 3
    John Mohr
    John Mohr, SVP, Clinical Development and Medical Affairs - scPharmaceuticals
  13. The Promise of Personalized Treatment Becoming Reality: How INT Could Change Oncology
    Breakout Session
    • Oncology
    26A

    merck logo

    Cynthia Bens
    Cynthia Bens, Senior Vice President - Personalized Medicine Coalition
    Scot Ebbinghaus
    Scot Ebbinghaus, Vice President and Therapeutic Area Head - Merck Research Laboratories
    Alicia Walker Rowell
    Alicia Walker Rowell, Vice President - AIM at Melanoma
    Michelle Brown
    Michelle Brown, Vice President, Portfolio Lead - Moderna
    Niklas Blomberg
    Niklas Blomberg, Executive Director - Innovative Health Initiative
  14. Thriving in the Age of Digital Insecurity: New Reporting Obligations and Cyber Resilience for Life Sciences Companies
    Breakout Session
    • AI and Digital Health
    24BC
    Justine Phillips
    Justine Phillips, Partner - Baker McKenzie
    Todd Hemmen
    Todd Hemmen, Chief, Cyber Technical Analytics and Operations Section, Cyber Division - US Department of Justice, Federal Bureau of Investigation
    Nick Arico
    Nick Arico, Supervisory Special Agent - US Department of Justice, Federal Bureau of Investigation
    Lisel Newton
    Lisel Newton, Senior Director, Information Security, Risk & Compliance - Gossamer Bio
    Anne Blake-Dreher
    Anne Blake-Dreher, Vice President and Assistant General Counsel - Perrigo
  15. Umoja Biopharma
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    David Fontana
    David Fontana, Chief Operating and Chief Business Officer - Umoja Biopharma
  16. Vaccinating Against Mistrust and Misinformation During an Infodemic
    Breakout Session
    • Infectious Disease and Vaccines
    30DE
    Amy Speak
    Amy Speak, Senior Director, Corporate Communications - Novavax, Inc.
    Reed Tuckson
    Reed Tuckson, Managing Director / Co-Founder - Tuckson Health Connections, LLC / Black Coaliition Against COVID-19
    Pedro Martinez
    Pedro Martinez, Director, Health - UnidosUS
    Miriam Mason
    Miriam Mason, Senior Advisor - Public Good Projects (PGP)
3:15 PM – 3:30 PM
(PST)
  1. Aruna Bio
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Stephen From
    Stephen From, CEO - Aruna Bio
  2. Chugai Pharmaceutical Co., Ltd.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Yumiko Asano
    Yumiko Asano, Head of Chugai Partnering - Chugai Pharmaceutical Co., Ltd.
  3. EG 427
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Don Haut
    Don Haut, Chief Business Officer - EG 427
  4. Lectenz Bio
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Lori Yang
    Lori Yang, CEO and CSO - Lectenz Bio
3:20 PM – 3:30 PM
(PST)
  1. BioProcess Insider Interviews: Enzene
    BioProcess Theater Session
    Abhishek Mathur
    Abhishek Mathur, Senior Vice President & Head of R&D - Enzene Inc
3:30 PM – 3:45 PM
(PST)
  1. BioProcess Insider Interviews: Purolite
    BioProcess Theater Session
    Hayley Crowe
    Hayley Crowe, Executive Vice President and General Manager, Global Life Sciences Sector - Purolite
  2. Data4Cure, Inc.
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Janusz Dutkowski
    Janusz Dutkowski, CEO and Co-founder - Data4Cure, Inc.
  3. GeneVentiv Therapeutics, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Damon Race
    Damon Race, CEO - GeneVentiv Therapeutics, Inc.
  4. Hillhurst Bio
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Andrew Gomperts
    Andrew Gomperts, President and CEO - Hillhurst Bio
  5. Terran Biosciences
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Sam Clark
    Sam Clark, Founder & CEO - Terran Biosciences
3:40 PM – 4:10 PM
(PST)
  1. Biomanufacturing Supply and Demand: Industry Trends and Projected Impacts
    BioProcess Theater Session BioProcess Theater
    Dawn Ecker
    Dawn Ecker, Managing Director, BioProcess Technology Group (BPTG) - BDO
3:45 PM – 4:00 PM
(PST)
  1. Gan & Lee Pharmaceuticals
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Spencer Carter
    Spencer Carter, Sr Director, US Business Development - Gan&Lee Pharmaceuticals
  2. Guangzhou Magpie Pharmaceuticals Co., Ltd.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Yuqiang Wang
    Yuqiang Wang, Chief Executive Officer - Guangzhou Magpie Pharmaceuticals CO., LTD.
  3. Pattern Computer
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Mark Anderson
    Mark Anderson, Chair and CEO - Pattern Computer
  4. SIRPant Immunotherapeutics Inc
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Robert Towarnicki
    Robert Towarnicki, President & CEO - SIRPant Immunotherapeutics Inc.
4:00 PM – 4:15 PM
(PST)
  1. Biopico Systems Inc
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    John Collins
    John Collins, CEO - Biopico Systems Inc
  2. Immunis, Inc.
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Hans Keirstead
    Hans Keirstead, Chairman of the Board - Immunis, Inc.
  3. IRBM
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Carlo Toniatti
    Carlo Toniatti, Chief Scientific Officer - IRBM
  4. Kinoxis Therapeutics
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Hugh Alsop
    Hugh Alsop, CEO - Kinoxis Therapeutics Pty Ltd
4:15 PM – 4:30 PM
(PST)
  1. Adult Vaccination: New Vaccines, New Opportunities to Protect Public Health
    Breakout Session
    • Infectious Disease and Vaccines
    32AB

    merck logo

    Phyllis Arthur
    Phyllis Arthur, Senior Vice President, Infectious Disease & Emerging Science Policy - Biotechnology Innovation Organization (BIO)
    Jannie Oosthuizen
    Jannie Oosthuizen, President, Merck Human Health U.S. - Merck
    Abby Bownas
    Abby Bownas, Manager - Adult Vaccine Access Coalition
    Michael Hodin
    Michael Hodin, CEO; Managing Partner - Global Coalition on Aging; High Lantern Group
    Jia Hu
    Jia Hu, CEO - 19 to Zero
  2. Biotech as Climate Tech: Sustainable Production in Pharma, Ag, and Industry
    Breakout Session
    • Widening the Bioeconomy
    29C
    Angela Ailloni
    Angela Ailloni, VP, Business Development - Ginkgo Bioworks
    Adrienne Davenport
    Adrienne Davenport, Managing Director - BASF Bioservices
    Christina Smolke
    Christina Smolke, CEO - Antheia, Inc
    Sasha Calder
    Sasha Calder, Head of Impact - Geno
  3. Chimeric Therapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Rebecca McQualter
    Rebecca McQualter, COO - Chimeric
  4. Co-opting Biological Processes to Drug Cancer and Other Diseases
    Breakout Session
    • Oncology
    26B
    Mariana Mihalusova
    Mariana Mihalusova, Investor - Venrock
    Larry Hamann
    Larry Hamann, Co-founder/CEO - Interdict Bio
    Aetna Wun Trombley
    Aetna Wun Trombley, CEO - Lycia
    Bernd Boidol
    Bernd Boidol, CEO - Proxygen
    George Eliades
    George Eliades, CEO - Mythic Therapeutics, Inc.
  5. Enhancing Clinical Trial Diversity Through a Patient-Centric, Data Driven Approach
    Breakout Session
    • Diversity‚ Equity and Inclusion
    31C
    Elena Martinez
    Elena Martinez, Professor, Herbert Wertheim School of Public Health and Human Longevity Science; Associate Director of Population Sciences - UC San Diego Moores Cancer Center
    Trevan Locke
    Trevan Locke, Assistant Research Director - Duke-Margolis Institute for Health Policy
    Megan Fesinmeyer
    Megan Fesinmeyer, Observational Research Senior Manager - Amgen
    Carla Rodriguez-Watson
    Carla Rodriguez-Watson, Director of Research - Reagan-Udall Foundation for the FDA
    Darryl Sleep
    Darryl Sleep, Head, Global Public Health - Amgen
  6. Evolution of the IRA: A New-Year, a Potential New Administration, Yet Tackling the Same Access and Affordability Challenges
    Breakout Session
    • Value‚ Patient Access and Reimbursement
    23BC
    Stephen Morales
    Stephen Morales, Senior Principal - Blue Fin Group, An IntegriChain Company
    Gerry Gleeson
    Gerry Gleeson, Head of US Market Access - Sanofi
    Bill Sarraille
    Bill Sarraille, Adjunct Professor - University of Maryland Francis King Carey School of Law
    Albert Thigpen
    Albert Thigpen, Operating Advisor - Nautic Partners
    Bill Roth
    Bill Roth, Founding Partner - Blue Fin Group
  7. Fireside Chat
    Fireside Chat with FDA Commissioner Dr. Robert Califf
    Fireside Chat
    • Regulatory Innovation
    25ABC
    John Crowley
    John Crowley, President & CEO - Biotechnology Innovation Organization (BIO)
    Robert Califf
    Robert Califf, FDA Commissioner - U.S. Food and Drug Administration
  8. Freedom Biosciences
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Dina Burkitbayeva
    Dina Burkitbayeva, CEO - Freedom Biosciences
  9. IPOs Are Starting to Come Back: Are You Ready?
    Breakout Session
    • Business Development and Finance
    29AB
    Rich Ramko
    Rich Ramko, Partner, US Biotech Leader - EY (Ernst & Young)
    Steven Spector
    Steven Spector, Executive Vice President, Head of Business Development and General Counsel - Longboard Pharma
    Brad Wolff
    Brad Wolff, Senior Managing Director |Global Advisory | Strategic Advisory | Mergers and Acquisition - Evercore
    Arvind Kush
    Arvind Kush, CFO - RayzeBio
    Kristin VanderPas
    Kristin VanderPas, Partner - Cooley
  10. Moving from the Lab Bench to the Biotech C-Suite: Insights on Running a Founder-Led Biotech
    Breakout Session
    • Translational Research
    31AB
    Max Bayer
    Max Bayer, Reporter - Endpoints News
    Kevin Parker
    Kevin Parker, CEO and Co-founder - Cartography Biosciences
    Jordi Mata-Fink
    Jordi Mata-Fink, CEO and Co-founder - Gate Bioscience
    Trevor Martin
    Trevor Martin, CEO and Co-founder - Mammoth Biosciences
    Kira Poskanzer
    Kira Poskanzer, Founder-in-Residence - Arcadia Science
    Heather Bowerman
    Heather Bowerman, CEO & Founder - DotLab
  11. Overcoming Systemic Data Bias via AI and Digital Health Tools: Perspectives from Providers, Pharma and Innovators
    Breakout Session
    • AI and Digital Health
    24BC
    Alexis Bortniker
    Alexis Bortniker, Partner - Cooley LLP
    Erin Parks
    Erin Parks, Co-founder and Chief Clinical Officer - Equip Health
    Shane Case
    Shane Case, Global Head of Privacy, Ethics and Policy Governance - Illumina
  12. Policy and Practice Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Precision Oncology
    Breakout Session
    • Diagnostics and Personalized Medicine
    26A
    Daryl Pritchard
    Daryl Pritchard, Senior Vice President - Personalized Medicine Coalition
    Jonathan Katchmore
    Jonathan Katchmore, Vice President of Commercial Diagnostic Strategy - Eli Lilly
    Peter Hulick
    Peter Hulick, Medical Director, Center for Personalized Medicine - NorthShore / Endeavor Health
    Robert Dumanois
    Robert Dumanois, Director, Reimbursement Strategy - Thermo Fisher Scientific
    Wendy Levin
    Wendy Levin, Chief Medical Officer - Biofidelity
  13. SPOC Proteomics
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Bharath Takulapalli
    Bharath Takulapalli, CEO - SPOC Proteomics, Inc.
  14. Yifan Pharmaceutical
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Simon Li
    Simon Li, CEO/CMO of Evive Biotech and Vice President - Yifan Pharmaceutical
4:30 PM – 4:45 PM
(PST)
  1. Brii Biosciences
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Susannah Cantrell
    Susannah Cantrell, Chief Business Officer - Brii Biosciences
  2. Cradle
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 3
    Elise de Reus
    Elise de Reus, Co-Founder - Cradle
  3. Nanoscope Therapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 1
    Sulagna Bhattacharya
    Sulagna Bhattacharya, CEO - Nanoscope Therapeutics
  4. Sobrera Pharma
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Ann-Charlotte ROSENDAHL
    Ann-Charlotte ROSENDAHL, CEO - Sobrera Pharma
4:45 PM – 5:00 PM
(PST)
  1. bBHC
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 3
    Mindy Min -Sun oh
    Mindy Min -Sun oh, CEO - bBHC
  2. Manifold Bio
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 4
    Gleb Kuznetsov
    Gleb Kuznetsov, Co-Founder & CEO - Manifold Bio
  3. ProtaBody, Inc.
    Company Presentation
    • Multiple Therapeutics
    Company Presentation Theater 2
    Justin Chartron
    Justin Chartron, CSO - ProtaBody, Inc.
  4. Zymedi
    Company Presentation
    • Inflammation
    Company Presentation Theater 1
    Scott Kim
    Scott Kim, Chief Business Officer - Zymedi
7:00 PM – 9:00 PM
(PST)
  1. Gas Lamp Block Party
    Reception
9:00 AM – 10:00 AM
(PST)
  1. Achieving the WHO Cervical Cancer Elimination Targets: The Value of Innovation in Achieving Pivotal Public Health Goals
    Breakout Session
    • Infectious Disease and Vaccines
    23BC

    merck logo

    Citseko Staples Miller
    Citseko Staples Miller, Managing Director, Healthcare and Life Science - FTI Consulting
    Beth Battaglino
    Beth Battaglino, CEO - HealthyWomen
    Jenelle Krishnamoorthy
    Jenelle Krishnamoorthy, Vice President, Head of Global Public Policy and International Affairs - Merck
    Joanna Sickler
    Joanna Sickler, Vice President - Roche Diagnostics
  2. Exploring Deal-Making Options for Your Portfolio of Assets
    Breakout Session
    • Business Development and Finance
    29AB
    Nisha Nanda
    Nisha Nanda, Group Vice President, Business Development - Eli Lilly
    Adam Rosenthal
    Adam Rosenthal, CEO and Founder - Star Therapeutics
    Bassil Dahiyat
    Bassil Dahiyat, President and Chief Executive Officer - Xencor, Inc.
    James Mutamba
    James Mutamba, Chief Business Officer - Arrakis Therapeutics
    Caroline Stark Beer
    Caroline Stark Beer, Chief Business Officer - Jnana Therapeutics
  3. Immune System Biomarkers: Can Our Antibodies Predict How We Will React to Disease and Immunotherapy?
    Breakout Session
    • Diagnostics and Personalized Medicine
    26A
    Moira Gunn
    Moira Gunn, Radio Host - BiotechNation
    Martin Gouldstone
    Martin Gouldstone, Chief Executive Officer - Oncimmune
    G. Scott Chandler
    G. Scott Chandler, Global Head, Personalized Health Care (PHC) Safety - F. Hoffmann-La Roche
    Justina Fert-Bober
    Justina Fert-Bober, Project Scientist - Cedars Sinai Medical Center
    Prem Premsrirut
    Prem Premsrirut, CEO and President - Mirimus
  4. New Approaches in Radiopharmaceuticals
    Breakout Session
    • Oncology
    31AB
    Karen Tkach Tuzman
    Karen Tkach Tuzman, Director of Biopharma Intelligence, Head of Discovery and Preclinical Research - BioCentury
    Dave Greenwald
    Dave Greenwald, CEO of Aviko Radiopharmaceuticals and vice president, business development - Deerfield Management
    Ken Song
    Ken Song, former CEO - RayzeBio
    Suji Jeong
    Suji Jeong, Founding Partner - The SJR Group
    Jeevan Virk
    Jeevan Virk, Therapeutic Area Strategy Head - Novartis
  5. Revolutionizing Clinical Trials: Patient Registries, Wearable Tech, and Video Capture
    Breakout Session
    • Clinical Trials Innovations
    26B
    Klaus Romero
    Klaus Romero, Chief Executive Officer, Chief Science Officer - Critical Path Institute
    Allison Moore
    Allison Moore, Founder/CEO - Hereditary Neuropathy Foundation
    Tina Duong
    Tina Duong, Director of Clinical Outcomes Research and Development - Stanford University
    Jason Colquitt
    Jason Colquitt, CEO - Across Healthcare
    Michelle Campbell
    Michelle Campbell, Associate Director, Stakeholder Engagement & Clinical Outcomes, Office of Neuroscience - FDA
  6. Surviving Turbulence: Extending Runway and Creating Value in Healthcare and Biotech
    Breakout Session
    • Business Development and Finance
    32AB
    Gwendolyn Wu
    Gwendolyn Wu, Reporter - BioPharma Dive
    Nate Chang
    Nate Chang, Operating Partner, Life Sciences - Playground Global
    Andy Seid
    Andy Seid, Partner - Bioluminescence Ventures
    Ayman AlAbdallah
    Ayman AlAbdallah, Partner - Mubadala Capital
    Carolyn Ng
    Carolyn Ng, Partner and Managing Director - TPG Life Sciences Innovations
  7. The US Supreme Court and the End of Scientific Deference?
    Breakout Session
    • Regulatory Innovation
    31C
    Stacy Amin
    Stacy Amin, Former FDA Chief Counsel - Morrison Foerster
    Zach Howe
    Zach Howe, Assistant U.S. Attorney, Southern District of California
    Judy Haron
    Judy Haron, Assistant General Counsel - PhRMA
    Vanessa Burrows
    Vanessa Burrows, Partner - Simpson Thacher & Bartlett LLP
  8. What’s Nex-T: Innovator Roundtable on T Cell Therapies in Oncology
    Breakout Session
    • Oncology
    24BC
    Angus Liu
    Angus Liu, Deputy Editor - Fierce Pharma
    Keir Loiacono
    Keir Loiacono, Chief Executive Officer - BlueSphere Bio
    Dan Passeri
    Dan Passeri, Chief Executive Officer - Cue Biopharma
    David Fontana
    David Fontana, Chief Operating and Chief Business Officer - Umoja Biopharma
    Lola Fashoyin-Aje
    Lola Fashoyin-Aje, Director, Office of Clinical Evaluation|(Cellular, Tissue, Gene Therapies) - Office of Therapeutic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
10:15 AM – 11:15 AM
(PST)
  1. Advancing the Global Regulatory Decision-Making with Public Private Partnerships
    Breakout Session
    • Regulatory Innovation
    31C
    Susan Winckler
    Susan Winckler, CEO - Reagan-Udall Foundation for the FDA
    Klaus Romero
    Klaus Romero, Chief Executive Officer, Chief Science Officer - Critical Path Institute
    Adora Ndu
    Adora Ndu, Chief Regulatory Affairs Officer - BridgeBio
    Carlos Garner
    Carlos Garner, Senior Vice President, Global Regulatory Affairs - Eli Lilly
    Peter Marks
    Peter Marks, Director, Center for Biologics Evaluation and Research (CBER) - U.S. Food and Drug Administration
  2. Approaching the Tipping Point: The Emergence of Allogeneic Cell Therapy for Oncology
    Breakout Session
    • Oncology
    31AB
    George Eastwood
    George Eastwood, Board Chair/Interim Executive Director - The Emily Whitehead Foundation
    Cokey Nguyen
    Cokey Nguyen, Chief Scientific and Technical Officer - Atara Biotherapeutics
    Abigail Jenkins
    Abigail Jenkins, Former President & CEO - Gamida Cell
    P.K. Morrow
    P.K. Morrow, Senior Vice President and Head of Oncology Therapeutic Area Unit - Takeda
    Kristin Yarema
    Kristin Yarema, President & CEO - Poseida Therapeutics
  3. Changing the Game: Innovation to End HIV
    Breakout Session
    • Infectious Disease and Vaccines
    23BC
    Cecilia Chung
    Cecilia Chung, Senior Director, Strategic Initiatives and Evaluation - Transgender Law Center
    Micheal Ighodaro
    Micheal Ighodaro, Co-Executive Director - Prevention Access Campaign
    Jenelle Krishnamoorthy
    Jenelle Krishnamoorthy, Vice President, Head of Global Public Policy and International Affairs - Merck
    Ji Ma
    Ji Ma, Head of Discovery - Brii Biosciences
    Sandra Thurman
    Sandra Thurman, Senior Advisor to the Division of Global HIV and Tuberculosis - CDC
  4. Competing as a Diagnostic Company in the Current Funding Environment: New Funding Models
    Breakout Session
    • Diagnostics and Personalized Medicine
    26A
    Jonathan Grinstein
    Jonathan Grinstein, Senior Editor - Inside Precision Medicine
    Bernard Peperstraete
    Bernard Peperstraete, CEO and Co-Founder - AcuamarkDx
    Michele Colucci
    Michele Colucci, Founder & Managing Partner - DigitalDx Ventures
    Alan Liu
    Alan Liu, Founder and Chief Operating Officer - Persperion Diagnostics
  5. Inside the VC Playbook: Overcoming Obstacles in Challenging Markets for Success
    Breakout Session
    • Business Development and Finance
    32AB
    Kimberly Ha
    Kimberly Ha, Founder - KKH Advisors
    Andrew Lam
    Andrew Lam, Head of Biotech Investment - Ally Bridge Group
    Enoch Kariuki
    Enoch Kariuki, President - Endeavor Biomedicines
    Carol Gallagher
    Carol Gallagher, Independent Director
    Jakob Dupont
    Jakob Dupont, Executive Partner - Sofinnova Investments
  6. Is Oncology Still a Hot Spot for Biopharma Deals?
    Breakout Session
    • Oncology
    24BC
    Ashwin Singhania
    Ashwin Singhania, Partner/Principal - EY (Ernst & Young)
    Ben Hickey
    Ben Hickey, President - RayzeBio
    Christopher Mortko
    Christopher Mortko, Vice President, Head of Search and Evaluation, Business Development & Licensing - Merck
    Ross Aarons
    Ross Aarons, Director, Corporate Development - Jazz Pharmaceuticals
    Camille Landis
    Camille Landis, Chief Business Officer and Chief Financial Officer - T-knife Therapeutics
  7. Partnering with ARPA-H: New Opportunities and Best Practices for Engaging a Transformative R&D Funder
    Breakout Session
    • Business Development and Finance
    29AB
    Susan Monarez
    Susan Monarez, Deputy Director - Advanced Research Projects Agency for Health (ARPA-H)
    Jason Roos
    Jason Roos, Director, Scalable Solutions - Advanced Research Projects Agency for Health (ARPA-H)
    Wade Shen
    Wade Shen, Director, Proactive Health - Advanced Research Projects Agency for Health (ARPA-H)
    Stan Wang
    Stan Wang, CEO & Founder - Thymmune
    Yoseph Kim
    Yoseph Kim, CEO - Optosurgical
  8. Regulators & DTRA Enabling DCTs
    Breakout Session
    • Clinical Trials Innovations
    26B
    Amir Kalali
    Amir Kalali, Co Chair - DTRA
    Jane Myles
    Jane Myles, Program Director - DTRA
    Rasika Kalamegham
    Rasika Kalamegham, Head US Regulatory Policy - Genentech
    Steffen Thirstrup
    Steffen Thirstrup, Chief Medical Officer - European Medicines Agency (EMA)
    Michelle Campbell
    Michelle Campbell, Associate Director, Stakeholder Engagement & Clinical Outcomes, Office of Neuroscience - FDA
10:30 AM – 11:00 AM
(PST)
  1. Company Presentations Thursday
    Company Presentation Session Company Presentation Theaters
    johnson and johnson
  2. Editpep
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Genine Winslow
    Genine Winslow, CEO - Editpep
  3. Macro Biologics
    Company Presentation
    • Infectious Disease and Vaccines
    Company Presentation Theater 1
    Michael Bevilacqua
    Michael Bevilacqua, CEO, CSO, Director, & Co-Founder - Macro Biologics
  4. Risked Based Approach Commissioning and Qualification for organizations
    BioProcess Theater BioProcess Theater
10:45 AM – 11:00 AM
(PST)
  1. Biorchestra
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    David Oxley
    David Oxley, Chief Business Officer - Biorchestra
  2. Cairn Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Scott Evangelista
    Scott Evangelista, Chief Executive Officer - Cairn Therapeutics
11:00 AM – 1:00 PM
(PST)
  1. Celine Biotechnologies
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Nina Keshavarzi
    Nina Keshavarzi, Founder & CEO - Celine Therapeutics
  2. Endure Biotherapeutics, Inc.
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Mark Wilson
    Mark Wilson, CEO - Endure Biotherapeutics, Inc.
  3. EpiAxis Therapeutics
    Company Presentation
    • Oncology
    Company Presentation Theater 1
    Jeremy Chrisp
    Jeremy Chrisp, CEO - EpiAxis Therapeutics
  4. Human Biome Institute
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Jarek Bilinski
    Jarek Bilinski, AI-powered Drug Development Platform for creating microbiome based therapies - Human Biome
  5. L&J Bio,Co.,Ltd.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Kwan Hee Lee
    Kwan Hee Lee, MD, PhD and Chief Technical officer - L&J Bio, Co.,Ltd.
  6. Leverna Therapeutics
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Avery Yan
    Avery Yan, Co-Founder, President & CSO/COO - Leverna Therapeutics
  7. Origami Therapeutics, Inc.
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Beth Hoffman
    Beth Hoffman, Founder and CEO - Origami Therapeutics, Inc.
  8. Papillon Therapeutics, Inc.
    Start-Up Stadium Session
    • CNS/Neurological
    5B
    Carter Cliff
    Carter Cliff, CEO - Papillon Therapeutics, Inc.
  9. Start-Up Stadium Thursday
    Start-Up Stadium 5B
  10. Suntec Medical
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Pauline Lau
    Pauline Lau, Founder - Suntec Medical
  11. Talent Development for a Digital World
    BioProcess Theater BioProcess Theater
    Jeff Boesiger
    Jeff Boesiger, Managing Partner - Ospree Consulting
    Tyler DeWitt
    Tyler DeWitt, Executive Director of Innovation - Virtuosi VR
    Brian Berquist
    Brian Berquist
    Animesh Ray
    Animesh Ray, Professor, Systems Biology - Henry Riggs School of Applied Life Sciences Keck Graduate Institute
    James Dekloe
    James Dekloe
  12. Trust Bio-sonics Inc.
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Chung-Hsin Wang
    Chung-Hsin Wang, General Manager - Trust Bio-sonics Inc.
  13. Vyro Bio Inc
    Start-Up Stadium Session
    • Platform for Therapeutics
    5B
    Carolini Kaid
    Carolini Kaid, CEO/CSO - Vyro Bio Inc
11:15 AM – 11:30 AM
(PST)
  1. IASO Biotherapeutics
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 2
    Alan Fu
    Alan Fu, CFO - IASO
  2. Upkara
    Company Presentation
    • Tools/Drug Development Support Tech
    Company Presentation Theater 1
    Rich Troyer
    Rich Troyer, CEO - Upkara
11:30 AM – 12:45 PM
(PST)
  1. Allife Medicine
    Company Presentation
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 2
    Zemin Ning
    Zemin Ning, Dr Zemin Ning - ALLIFE Medicine
  2. Immerse Yourself in the XR Future of Healthcare: Virtual Reality Demos and More
    Special Program
    • AI and Digital Health
    32AB
    Gail Gannon
    Gail Gannon, Director, Neurotech Collider Lab, Bakar BioEnginuity Hub - University of California, Berkeley
    Walter Greenleaf
    Walter Greenleaf, Neuroscientist, VR & Digital Health Expert - Virtual Human Interaction Lab, Stanford
    Julia Scott
    Julia Scott, CEO Gambit Labs & Director of Brain and Memory Care Lab - University of Santa Clara
    Mylea Charvat
    Mylea Charvat, Chief Medical Officer - Altoida
    Mark Edwards
    Mark Edwards, CEO and Founder - ViewMind
    Lincoln Nguyen
    Lincoln Nguyen, CEO - Karuna Labs
    Alex Azzi
    Alex Azzi, Co-founder and CEO - XR Workout
    Andreas Forsland
    Andreas Forsland, CEO - Cognixion
    Veena Somareddy
    Veena Somareddy, Co-founder & CEO - Neuro Rehab VR
    Nathan Pettyjohn
    Nathan Pettyjohn, CEO - The Immerse Group
11:45 AM – 12:00 PM
(PST)
  1. Amaro Therapeutics, Inc.
    Company Presentation
    • Metabolic Diseases
    Company Presentation Theater 1
    J Michael French
    J Michael French, Chief Executive Officer - Amaro Therapeutics, Inc.
  2. Hopstem Biotechnology
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Jing Fan
    Jing Fan, Founder and CEO - Hopstem Biotechnology
12:00 PM – 12:15 PM
(PST)
  1. BreakBio Corp
    Session
    • Oncology
    Company Presentation Theater 1
    Roy DeSouza
    Roy DeSouza, CEO and Co-Founder - BreakBio Corp
  2. Neurobiogen
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Changjoon Lee
    Changjoon Lee, professor and scientific advisory board - Neurobiogen
12:15 PM – 12:30 PM
(PST)
  1. AriBio Co., Ltd.
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 1
    Fred Kim
    Fred Kim, Managing Director - AriBio Co., Ltd.
  2. Astrogen
    Company Presentation
    • CNS/Neurological
    Company Presentation Theater 2
    Su-Kyeong Hwang
    Su-Kyeong Hwang, CEO - Astrogen
3:00 PM – 4:00 PM
(PST)
  1. Closing Happy Hour
    Reception Sails Pavilion and the Terrace

white squarewhite

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS

Loading

Search